Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2009 Annual Meeting | Poster Session 08

Thursday 04/30/09
11:30 AM - 02:30 PM Add To Calendar
This program will be presented both in-person and online
This program is not expected to be available in the meeting's On Demand product.
Scientific Poster Session
Cerebrovascular Disease and Interventional Neurology, Movement Disorders, Aging and Dementia, Anterior Horn, Child Neurology/Developmental Neurobiology, Epilepsy, Interventional Neurology, MS and Related Diseases, Neural Repair/Rehabilitation, Neurogenetics and Gene Therapy
No CME available
Event Timeline
11:30 AM - 02:30 PM Abstract 001 - Acetylcholinesterase Is Overexpressed in ALS Mice and Antisense Inhibition Prolongs Survival
11:30 AM - 02:30 PM Abstract 002 - Autophagic Alteration in the Spinal Cord Motor Neurons of ALS Mice: Possible Link to Selective Motor Neuron Degeneration
11:30 AM - 02:30 PM Abstract 003 - CD4+ T Cells Protect Motoneurons by Inducing Alternatively Activated (M2) Microglia in a Mouse Model of ALS
11:30 AM - 02:30 PM Abstract 004 - Effective Suppression of Spasticity in Baclofen Tolerant Rats after Spinal or Systemic Treatment with the Selective AMPA Receptor Antagonist Tezampanel
11:30 AM - 02:30 PM Abstract 005 - An Investigation of SOD1 Behaviour in Amyotrophic Lateral Sclerosis
11:30 AM - 02:30 PM Abstract 006 - Passive Immunization Using Monoclonal Antibodies Specific for Mutant SOD1 Delayed Mortality in ALS G93A Mutant SOD1 Mice
11:30 AM - 02:30 PM Abstract 007 - Higher Molecular Weight Species of SQSTM1/p62 Accumulate in Protein Aggregates in a Mouse Model of Amyotrophic Lateral Sclerosis
11:30 AM - 02:30 PM Abstract 008 - Rat Brain Mitochondrial Calcium Retention Capacity [CRC] Exceeds Total Brain Calcium While Rat Spinal Cord CRC Is 90 Percent Less Than the Available Total Spinal Cord Calcium
11:30 AM - 02:30 PM Abstract 009 - Genetic and Cellular Studies of the Hereditary Spastic Paraplegia Gene REEP1
11:30 AM - 02:30 PM Abstract 010 - Histopathologic Changes of the Enteric Nervous System in ALS
11:30 AM - 02:30 PM Abstract 011 - Retrospective Analysis of Response to Medical Treatment of Peripheral Neuropathy Symptoms in Clinical Practice
11:30 AM - 02:30 PM Abstract 012 - Anterior Lobe and Cerebellar Atrophy in Sensory Neuron Diseases
11:30 AM - 02:30 PM Abstract 013 - Distinct Pattern of Amyloid Deposition in Gelsolin Amyloidosis
11:30 AM - 02:30 PM Abstract 014 - Low Dose Pyridoxine and Reversible Neurotoxicity
11:30 AM - 02:30 PM Abstract 015 - Multimodal Determinants of Multiple Sclerosis Outcome in Children with Central Nervous System Demyelination
11:30 AM - 02:30 PM Abstract 016 - Viral Seroprevalence among Canadian Children Presenting with Acquired Demyelination of the Central Nervous System
11:30 AM - 02:30 PM Abstract 017 - Cognitive and Psychological Functioning in Pediatric-Onset Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 018 - Spinal MRI in Pediatric Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 019 - Relationship between Age of Onset and Duration and Neurocognitive Status in Pediatric MS
11:30 AM - 02:30 PM Abstract 020 - Use of Plasmapheresis in Pediatric Demyelinating Disease
11:30 AM - 02:30 PM Abstract 021 - White Matter Tract Based DTI Analysis in Pediatric Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 022 - Depression in Pediatric MS Patients Correlates with Increased Disease Severity and Selective Neuropsychological Deficits
11:30 AM - 02:30 PM Abstract 023 - Daclizumab Add-On Therapy for Pediatric Multiple Sclerosis Patients Failing Interferon
11:30 AM - 02:30 PM Abstract 024 - Cerebrospinal Fluid Characteristics of Acquired Demyelinating Syndromes of the Central Nervous System in Children
11:30 AM - 02:30 PM Abstract 025 - Regional and Tract Based DTI Analysis of Normal Appearing White Matter in Pediatric Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 026 - Melanocortin Receptor-1 Gene Polymorphisms and Multiple Sclerosis Outcome
11:30 AM - 02:30 PM Abstract 027 - Temporal Variation of Onset of Relapses in Multiple Sclerosis: Results from the Northern and Southern Hemispheres in the MSBase Registry
11:30 AM - 02:30 PM Abstract 028 - Threefold Increase in Migraine in MS Patients Compared to Age- and Gender-Matched Population Controls
11:30 AM - 02:30 PM Abstract 029 - Progranulin Genetic Variability in a Population of 239 Patients with Primary Progressive Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 030 - Challenging the Role of Chromosome X Inactivation in Multiple Sclerosis Pathogenesis
11:30 AM - 02:30 PM Abstract 031 - HLA-DRB1*-DQB1* and Multiple Sclerosis in Argentina
11:30 AM - 02:30 PM Abstract 032 - Gender Differences in Disease and Therapy Management in MS: Evidence from a Community Health Survey
11:30 AM - 02:30 PM Abstract 033 - Demographic and Clinic Characteristics of Patients Treated with Tysabri in the Real Situation of Prescription Compared with AFFIRM Study
11:30 AM - 02:30 PM Abstract 034 - Unusual Presentation of Multiple Sclerosis in Four Caucasian Patients Carrying a Mutation in the MEFV Gene
11:30 AM - 02:30 PM Abstract 035 - Prevalence of Dysfagia in Multiple Sclerosis: An Italian Multicenter Study
11:30 AM - 02:30 PM Abstract 036 - Epidemiology and Current Treatment Trends of Multiple Sclerosis in Pakistan
11:30 AM - 02:30 PM Abstract 037 - Sexual Dysfunction in Multiple Sclerosis: Gender Basis Differences
11:30 AM - 02:30 PM Abstract 038 - High Frequency of Impaired Glucose Tolerance and Diabetes in Patients with Progressive Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 039 - The Clinical and Immunological Comparison of Limited Disseminated Demyelinating Diseases and Conventional Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 040 - CD24 Polymorphism and Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 041 - The Prevalence of Multiple Sclerosis in the Italian Province of Frosinone
11:30 AM - 02:30 PM Abstract 042 - Prophylactic and Therapeutic Treatment with IFN-lambda, a Novel Type III Interferon, Has Potent Efficacy in a Relapsing-Remitting EAE Model
11:30 AM - 02:30 PM Abstract 043 - HSP70 Overexpression in Oligodendrocytes Enhance EAE
11:30 AM - 02:30 PM Abstract 044 - Nicotinic Attenuation of Central Nervous System Inflammation and Autoimmunity
11:30 AM - 02:30 PM Abstract 045 - Alteration of B Cell Cytokine and Growth Factors in Experimental Autoimmune Encephalomyelitis by Glatiramer Acetate
11:30 AM - 02:30 PM Abstract 046 - Recombinant Invariant Chains Induce Different Responses in CNS-Specific Effector and Regulatory T Cell Populations
11:30 AM - 02:30 PM Abstract 047 - Fingolimod Enhances Myelin Basic Protein Expression and Modulates Cytokine Production Following an Interferon-gamma Mediated Insult in the Whole Brain Aggregate Cell Culture System
11:30 AM - 02:30 PM Abstract 048 - Histopathology of the Murine Cuprizone Model for Multiple Sclerosis (MS)
11:30 AM - 02:30 PM Abstract 049 - MRI Detectable Spinal Cord Atrophy Correlates with Disability in a Murine Model of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 050 - p75NTR-Knockout Mice Feature Increased Axonal Vulnerability in Experimental Autoimmune Encephalomyelitis
11:30 AM - 02:30 PM Abstract 051 - Laquinimod Inhibits MOG-Induced Experimental Autoimmune Encephalomyelitis (EAE) in CD4+CD25+ Regulatory T-Cell Depleted Mice
11:30 AM - 02:30 PM Abstract 052 - Thalamic T2 Hypointensity Correlates with Disability in a Murine Model of Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 053 - Repetitive Pertussis Toxin Promotes Development of Regulatory T Cells and Prevents Central Nervous System Autoimmune Disease
11:30 AM - 02:30 PM Abstract 054 - Dimethyl Fumarate (BG00012) Inhibits Astrogliosis in Rodent EAE Models
11:30 AM - 02:30 PM Abstract 055 - The Therapeutic Effect of Pertussis Toxin Administered Intracerebroventricularly in an Animal Model of Experimental Autoimmune Encephalomyelitis
11:30 AM - 02:30 PM Abstract 056 - Reduced Adult Neurogenesis and Altered Emotional Behaviors in Autoimmune-Prone BAFF Transgenic Mice
11:30 AM - 02:30 PM Abstract 057 - Visualization of Encephalitogenic Effector T Cells during Fingolimod (FTY720) Treatment of Experimental Autoimmune Encephalomyelitis Using In Vivo 2-Photon Imaging
11:30 AM - 02:30 PM Abstract 058 - Ingested (oral) ACTH (Adreno-Cortico-Trophic Hormone/Corticotrophin) Inhibits Acute EAE
11:30 AM - 02:30 PM Abstract 059 - Acute and Long-Term Effects of Lacosamide in an Animal Model of Status Epilepticus
11:30 AM - 02:30 PM Abstract 060 - The Mammalian Target of Rapamycin (mTOR) Signaling Pathway Mediates Epileptogenesis in the Kainate Model of Temporal Lobe Epilepsy
11:30 AM - 02:30 PM Abstract 061 - Persistent vs. Non-Persistent Group I mGluR-Induced Network Activity: Implications for Epileptogenesis
11:30 AM - 02:30 PM Abstract 062 - Calcium Channels Contribute to a Prolonged Depolarization in the Bag Cell Neurons of Aplysia californica
11:30 AM - 02:30 PM Abstract 063 - Relationship of Peripheral Autonomic Nerve Activity and Limbic Cortical Seizures
11:30 AM - 02:30 PM Abstract 064 - Intracranial EEG Seizure - Onset Patterns and Surgical Outcomes in Patients with Refractory Epilepsy
11:30 AM - 02:30 PM Abstract 065 - Repeating EEG-Video Monitoring: Why and with What Results?
11:30 AM - 02:30 PM Abstract 066 - Gelastic Seizures and the Anteriomesial Frontal Lobe: A Case Report
11:30 AM - 02:30 PM Abstract 067 - Musicogenic Epilepsy with Independent Bilateral Temporal Seizures
11:30 AM - 02:30 PM Abstract 068 - Do Atmospheric Pressure Changes Influence Seizure Occurrence in the Epilepsy Monitoring Unit?
11:30 AM - 02:30 PM Abstract 069 - Memantine Treatment in Patients with Alzheimer's Disease: Neuropsychological Results from an Open-Label, Multi-Center Brain Imaging Trial
11:30 AM - 02:30 PM Abstract 070 - Relevance of Computerized Cognitive Assessment to Functional Disability in a Mildly Impaired Elderly Cohort
11:30 AM - 02:30 PM Abstract 071 - Mattis Dementia Rating Scale Distinguishes between Parkinson's Disease with Mild Cognitive Impairment (PD-MCI) and Amnestic-Mild Cognitive Impairment (A-MCI)
11:30 AM - 02:30 PM Abstract 072 - First Symptoms in Pathologically-Confirmed Corticobasal Degeneration, Progressive Supranuclear Palsy, and Frontotemporal Dementia with Motor Neuron Disease
11:30 AM - 02:30 PM Abstract 073 - Hippocampal Sclerosis Co-Existing with Parkinson's Disease Dementia
11:30 AM - 02:30 PM Abstract 074 - Clinical Improvements in Cognitive Function with 3D Video Gameplay
11:30 AM - 02:30 PM Abstract 075 - Telemedicine-Based Validation of the National Alzheimer's Coordinating Center Uniform Data Set in Normal Cognition, Mild Cognitive Impairment, and Dementia
11:30 AM - 02:30 PM Abstract 076 - Cerebrospinal Fluid Vitamin D Binding Protein Declines with Age
11:30 AM - 02:30 PM Abstract 077 - Extended-Release Memantine (28 mg, Once Daily) Improves Verbal Fluency and Behavior in Patients with Moderate to Severe Alzheimer's Disease: Results of a Multinational, Double-Blind, Placebo-Controlled Trial
11:30 AM - 02:30 PM Abstract 078 - Clinical Overlap between Creutzfeldt-Jakob Disease and Dementia with Lewy Bodies
11:30 AM - 02:30 PM Abstract 079 - Dimebon Induces Neurite Outgrowth with Hippocampal, Spinal, and Cortical Neurons
11:30 AM - 02:30 PM Abstract 080 - PIN1 as New Target To Protect Synaptic Function in Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 081 - Presenilin 2 Modulates Microglial Activation In Vitro
11:30 AM - 02:30 PM Abstract 082 - Functional Validation Strategy for a Pilot Genome Scan of Alzheimer's Disease Neuropathology Suggests a Role for SEMA5A
11:30 AM - 02:30 PM Abstract 083 - rs5848 Variant Influences GRN mRNA Levels in Brain and Peripheral Mononuclear Cells from Patients with Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 084 - Diagnosis of Frontotemporal Lobar Degeneration Due to Progranulin Gene Mutations: Usefulness of Serum and Cerebrospinal Fluid Progranulin Dosage
11:30 AM - 02:30 PM Abstract 085 - GAB2 Gene Polymorphism in Italian Patients with Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 086 - A Polymorphism in ASPM Is Associated with Alzheimer Disease and Brain Size
11:30 AM - 02:30 PM Abstract 087 - APOE Gene Polymorphisms and Frontotemporal Dementia: A Meta-Analysis
11:30 AM - 02:30 PM Abstract 088 - Lipoprotein Profile and Interaction with Paraoxonase1 (PON1) and APOE Polymorphisms in Alzheimer's Disease
11:30 AM - 02:30 PM Abstract 089 - No Mutations in TARDBP, the Gene Encoding TDP-43, in UK Familial and Sporadic Parkinson's Disease Cases
11:30 AM - 02:30 PM Abstract 090 - Differential Effects of PINK1 Nonsense and Missense Mutations on Mitochondrial Function and Morphology
11:30 AM - 02:30 PM Abstract 091 - Prevalence of FMR1 Gray Zone Alleles Is Increased in Female Patients with Parkinsonism
11:30 AM - 02:30 PM Abstract 092 - Nigrostriatal Dopaminergic Functioning in Hereditary Parkinsonism Associated with PINK1 Mutations
11:30 AM - 02:30 PM Abstract 093 - The Increased Risk of Parkinson's Disease in Non-Smokers Is Dependent on Catechol-o-Methyltransferase (COMT) Genotype
11:30 AM - 02:30 PM Abstract 094 - PARK Locus and Related Genes, Environmental Exposures, and Parkinson's Disease (PD)
11:30 AM - 02:30 PM Abstract 095 - Demographic and Clinical Characteristics of LRRK2 G2019S Carriers in Early Onset PD
11:30 AM - 02:30 PM Abstract 096 - Heterozygous ATP13A2 Mutations Associated with Dopaminergic Dysfunction
11:30 AM - 02:30 PM Abstract 097 - Non-Motor Symptoms in Genetic Forms of Parkinson Disease
11:30 AM - 02:30 PM Abstract 098 - Selective Association of ALS-Linked Mutant SOD1 with HuR and TIAR in VEGF Destabilization and Down-Regulation
11:30 AM - 02:30 PM Abstract 099 - Association of the H63D Polymorphism in HFE with ALS in a Population of US Veterans
11:30 AM - 02:30 PM Abstract 100 - Loss of Heterozygosity Mapping in Irish Sporadic ALS Patients
11:30 AM - 02:30 PM Abstract 101 - Phenocopies in SOD1 Positive Familial Amyotrophic Lateral Sclerosis: Implications for Genetic Counseling and Research. From Case Report to Full Investigation
11:30 AM - 02:30 PM Abstract 102 - TARDBP Genotyping in Patients with Familial and Sporadic ALS: Identification of Two Novel Mutations
11:30 AM - 02:30 PM Abstract 103 - High Frequency of TARDBP Gene Mutations in Italian Patients with Amyotrophic Lateral Sclerosis (ALS)
11:30 AM - 02:30 PM Abstract 104 - High Resolution Melting (HRM) Analysis for Mutation Screening of the Cu/Zn Superoxide Dismutase 1 (SOD1) Gene
11:30 AM - 02:30 PM Abstract 105 - SOD1 Mutations in Familial Amyotrophic Lateral Sclerosis - Discordant D90A Genotype in Affected Twins
11:30 AM - 02:30 PM Abstract 106 - Exclusion of Glycyl-tRNA Synthetase (GARS) Gene Mutations in Hirayama Disease
11:30 AM - 02:30 PM Abstract 107 - Gene Screening in a French-Canadian Family with Primary Lateral Sclerosis and Identification of a New Family with the Same Phenotype
11:30 AM - 02:30 PM Abstract 108 - Brain Involvements Due to MFN2 Mutations
11:30 AM - 02:30 PM Abstract 109 - BDNF Val66Met Polymorphism and Brain Volumes in Multiple Sclerosis: A Relationship Still Debated
11:30 AM - 02:30 PM Abstract 110 - AAV-Follistatin Gene Therapy Targeting Neuromuscular Diseases with Weakness and Atrophy of the Quadriceps Muscle
11:30 AM - 02:30 PM Abstract 111 - Spastic Paraplegia, Optic Atrophy, and Neuropathy (SPOAN): New Observations, Locus Refinement, and Exclusion of Candidate Genes
11:30 AM - 02:30 PM Abstract 112 - Targeting the Nrf2 Pathway in Huntington's Disease: Therapeutic Efficacy of Dimethyl Fumarate in the R6/2 Mouse Model
11:30 AM - 02:30 PM Abstract 113 - Variation in the Alpha-Synuclein Gene, Independent of REP1, Modifies Risk for Parkinson's Disease
11:30 AM - 02:30 PM Abstract 114 - Common Variation in the LRRK2 Gene Is a Risk Factor for Parkinson's Disease
11:30 AM - 02:30 PM Abstract 115 - Genotype-Phenotype Correlation in a Transgenic Mouse Model of Machado-Joseph Disease
11:30 AM - 02:30 PM Abstract 118 - Restoration of Normal Function by Combinational Gene Replacement Using Follistatin and Micro-Dystrophin in Mdx Mice
11:30 AM - 02:30 PM Abstract 119 - Targeting the Expression of Transthyretin by the Choroid Plexus
11:30 AM - 02:30 PM Abstract 120 - Abnormal Glutamate Neurotransmission (GNT) in Adults with Ornithine Transcarbamylase Deficiency (OTCD)
11:30 AM - 02:30 PM Abstract 121 - Molecular Genetic Studies in Indian Patients with Megalencephalic Leukodystrophy
11:30 AM - 02:30 PM Abstract 122 - A New Sporadic Point Mutation in the ATP6 of the Mitochondrial DNA (mtDNA) in Leigh Disease
11:30 AM - 02:30 PM Abstract 123 - Classic Pelizaeus-Merzbacher Disease in a Girl with an Unbalanced Chromosomal Translocation and Functional Duplication of the PLP1 Gene
11:30 AM - 02:30 PM Abstract 124 - Clinical Characterization and Mapping of the Locus for a New Form of Childhood-Onset Leukodystrophy
11:30 AM - 02:30 PM Abstract 125 - Genetic Basis of Unidentifiable Arcuate Fasciculus in Children with Developmental Delay
11:30 AM - 02:30 PM Abstract 126 - Mutations in PEX10 Are a Cause of Autosomal Recessive Spinocerebellar Ataxia
11:30 AM - 02:30 PM Abstract 127 - Dropped Head Syndrome in a Child Due to a Lamin A/C Mutation
11:30 AM - 02:30 PM Abstract 128 - Comparative Genomic Hybridization (CGH) in the Diagnosis of Malformations of Cerebral Development
11:30 AM - 02:30 PM Abstract 129 - Familial Degenerative Encephalopathy with Intracranial Calcification and Metaphyseal Dysplasia
11:30 AM - 02:30 PM Abstract 130 - MUTFLOW: A Mutation Discovery Workflow
11:30 AM - 02:30 PM Abstract 131 - Changes in Haemocoagulation in Stroke Patients and Healthy Volunteers after a 1-Hour Continuous Ultrasound Monitoring Using a Diagnostic 2-4 MHz Transcranial Probe
11:30 AM - 02:30 PM Abstract 132 - Autophagy in Human Umbilical Vein Endothelial Cells Involved in Atherosclerosis:Degradation of Ox-LDL
11:30 AM - 02:30 PM Abstract 134 - Melatonin Neuroprotection during Focal Cerebral Ischemia
11:30 AM - 02:30 PM Abstract 135 - Clot Aspiration Plus Intrastriatal Administration of a Self-Assembling Peptide in a Rat Model of Intracerebral Hemorrhage
11:30 AM - 02:30 PM Abstract 136 - ATP-Sensitive Potassium (KATP) Channel Blockers Do Not Reverse the Neuroprotective Effect of a Ketogenic Diet in an Animal Model of Posthypoxic Myoclonus
11:30 AM - 02:30 PM Abstract 137 - Cysteine-Sparing Notch3 Mutation in a Patient with Migraines and Extensive White Matter Abnormalities
11:30 AM - 02:30 PM Abstract 138 - The Effect of Serum ADMA Levels on Infarct Volume and Prognosis in Patients with Acute Ischemic Stroke
11:30 AM - 02:30 PM Abstract 139 - Validation of a One-Dimensional Model of the Arterial Cerebral Circulation Using Ultrasound
11:30 AM - 02:30 PM Abstract 140 - Microalbuminuria in the Acute Phase of Ischemic Stroke and TIA
11:30 AM - 02:30 PM Abstract 141 - Hyperglycemia May Be Associated with Edema Progression in Acute Intracerebral Hemorrhage
11:30 AM - 02:30 PM Abstract 142 - Apocynin Decreases Consequences of Nitric Oxide Synthase Uncoupling in Experimental Neonatal Hypoxia-Ischemia
11:30 AM - 02:30 PM Abstract 143 - Changes in Protein Levels of Phosphorylated Akt and GSK 3 Beta May Not Contribute to the Protection of Lithium Against Focal Ischemia in Rats
11:30 AM - 02:30 PM Abstract 144 - Delayed Postconditioning Protects Against Focal Ischemic Brain Injury in Rats
11:30 AM - 02:30 PM Abstract 145 - Plasma Myeloperoxidase in Acute Brain Ischemia and High-Grade Carotid Stenosis
11:30 AM - 02:30 PM Abstract 146 - Pinoline: A Novel Neuroprotective Theraphy in Focal Cerebral Ischemia
11:30 AM - 02:30 PM Abstract 147 - ASIC2 Protein Is Required for Pressure-Induced Constriction in Mouse Middle Cerebral Artery and Prevention of Cerebral Edema
11:30 AM - 02:30 PM Abstract 148 - Hypoxia/Hypoglycemia Modulates Thrombin-Induced Release of Pro-Inflammatory Cytokines and Chemokines from Cultured Human Astrocytes
11:30 AM - 02:30 PM Abstract 149 - Caspase 3-Dependent Proteolytic Cleavage of TDP-43 in a Model of Transient Middle Cerebral Artery Occlusion
11:30 AM - 02:30 PM Abstract 150 - Metabolic Syndrome and CO2 Cerebral Vasomotor Reactivity
11:30 AM - 02:30 PM Abstract 151 - Prevalence of Vertebrobasilar System Abnormality in Patient with Vertigo
11:30 AM - 02:30 PM Abstract 152 - Clinical Outcome of Patients with Posterior Circulation Stroke Secondary to Bilateral Vertebral Artery Occlusion
11:30 AM - 02:30 PM Abstract 153 - Neuroprotective Effect of Near-Infrared Light Emitting Treatment in Stroke
11:30 AM - 02:30 PM Abstract 154 - Endovascular Treatment of Carotid Artery Stenosis by Stent Implantation
11:30 AM - 02:30 PM Abstract 155 - How Common Is Vertebral Artery Origin Stenosis in Hospitalized Patients Admitted with Ischemic Stroke? CT Angiography Study
11:30 AM - 02:30 PM Abstract 156 - Accelerated Locomotor Recovery after Augmented Stroke Rehabilitation
11:30 AM - 02:30 PM Abstract 158 - The Effects of Noradrenergic Stimulation on the Motor System of Stroke Patients
11:30 AM - 02:30 PM Abstract 159 - Differential Effects of Proton Pump Inhibitors on Functional Recovery Following Stroke
11:30 AM - 02:30 PM Abstract 160 - Results of a Phase I/IIa Prospective, Multicenter Clinical Trial To Assess the Safety and Efficacy of Cethrin in Adult Subjects with Acute Spinal Cord Injury (SCI)
11:30 AM - 02:30 PM Abstract 161 - Reduced Peroxisomal Proliferator Activator Receptor Gamma Co-Activator Alpha PGC-1alpha Levels in Hemiparetic Stroke Thigh Muscle May Be Reversed by Treadmill Exercise
11:30 AM - 02:30 PM Abstract 162 - Effect of Multiple Sclerosis Treatments on Growth of Neural Progenitor Cells In Vitro
11:30 AM - 02:30 PM Abstract 163 - Extensive Demyelinating Lesions: Clinical and MRI, Predictive and Evolutive Factors
11:30 AM - 02:30 PM Abstract 164 - Occurrence of Fatigue More Than 20 Years after Recovery from Guillain-Barre Syndrome
11:30 AM - 02:30 PM Abstract 165 - Locomotor Training May Improve Cognitive Performance in Persons with Multiple Sclerosis
11:30 AM - 02:30 PM Abstract 166 - Management of Refractory Orthostatic Hypotension in the First Month Following Acute Spinal Cord Injury
11:30 AM - 02:30 PM Abstract 167 - Pantoprazole Treatment Is Associated with More Rapid Recovery Following Ischemic and Hemorrhagic Stroke, Spinal Cord Injury, Traumatic Brain Injury and Other Types of CNS Injury
11:30 AM - 02:30 PM Abstract 168 - ICF-CY as a Roadmap for Projecting and Programming Rehabilitation in a Neuropaediatric Hospital Unit
11:30 AM - 02:30 PM Abstract 169 - Development of a Gravity Neutral Orthotic To Improve Arm Function in Severely Disabled Children with Spinal Muscular Atrophy (SMA)
11:30 AM - 02:30 PM Abstract 170 - Visualizing Axonal Integrity Following Neonatal Spinal Cord Injury Using Diffusion Tensor Imaging MRI
11:30 AM - 02:30 PM Abstract 171 - Improving Sleep: Initial Treatment of OIF/OEF Veterans with Blast-Induced Mild TBI
11:30 AM - 02:30 PM Abstract 172 - Ocular Pressure Test Shows Subtle Autonomic Cardiovascular Dysfunction in Patients with Mild Traumatic Brain Injury
11:30 AM - 02:30 PM Abstract 173 - Bruxism/Trismus Treated with Botulinum Toxin-A in a Severe Head Injury Patient
11:30 AM - 02:30 PM Abstract 174 - Impairment in Communicative Effectiveness in Parkinson's Disease
11:30 AM - 02:30 PM Abstract 175 - Animal Model of Corticobulbar and Corticospinal Dysfunction in Parkinson's Disease
12:00 PM - 01:30 PM Break
Faculty Disclosures
Gretchen L. Birbeck, MD, MPH, DTMH, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Birbeck has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Various. Dr. Birbeck has a non-compensated relationship as a Ambassador for Zambia with RSTMH that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Petra Kaufmann, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaufmann has received personal compensation for serving as an employee of Affinia Therapeutics. Dr. Kaufmann has received personal compensation for serving as an employee of Vigil Neuroscience. Dr. Kaufmann has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for DTx. Dr. Kaufmann has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Taysha Gene Therapies. Dr. Kaufmann has stock in Vigil Neuroscience. The institution of an immediate family member of Dr. Kaufmann has received research support from Cystic Fibrosis Foundation . Dr. Kaufmann has a non-compensated relationship as a Member of a Scientific Advisory Board with NIH that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
No disclosure on file
David S. Saperstein, MD No disclosure on file
Pinky H. Agarwal, MD, FÂ鶹´«Ã½Ó³»­ Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Supernus. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals Inc. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion Pharmaceuticals. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Acadia. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Kyowa Kirin. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal. Dr. Agarwal has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for AbbVie. Dr. Agarwal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine. Dr. Agarwal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AskBio. An immediate family member of Dr. Agarwal has stock in ALDEYRA THERAPEUTICS INC. An immediate family member of Dr. Agarwal has stock in Curis Inc. An immediate family member of Dr. Agarwal has stock in Citius Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Fortress Biotech. An immediate family member of Dr. Agarwal has stock in TG Therapeutics. An immediate family member of Dr. Agarwal has stock in ATYR PHARMA INC . An immediate family member of Dr. Agarwal has stock in CORVUS PHARMACEUTICALS INC . An immediate family member of Dr. Agarwal has stock in LAVA THERAPEUTICS . An immediate family member of Dr. Agarwal has stock in OVID THERAPEUTICS INC . An immediate family member of Dr. Agarwal has stock in TERNS PHARMACEUTICALS INC. An immediate family member of Dr. Agarwal has stock in VIKING THERAPEUTICS INC. Dr. Agarwal has stock in WAVE LIFE SCIENCES LTD. An immediate family member of Dr. Agarwal has stock in ProQr Therapeutics. An immediate family member of Dr. Agarwal has stock in Mind Medicine. An immediate family member of Dr. Agarwal has stock in Lyra Therapeutics. An immediate family member of Dr. Agarwal has stock in Larimer Therapeutics. An immediate family member of Dr. Agarwal has stock in Lantern Pharma. An immediate family member of Dr. Agarwal has stock in Black Diamond Therapeutics. An immediate family member of Dr. Agarwal has stock in Amylyx Pharma. An immediate family member of Dr. Agarwal has stock in Palisade Bio. An immediate family member of Dr. Agarwal has stock in Inozyme Pharma. An immediate family member of Dr. Agarwal has stock in Pyxis Oncology. An immediate family member of Dr. Agarwal has stock in Vertex Pharmaceuticals. An immediate family member of Dr. Agarwal has stock in Vyne Therapeutics. An immediate family member of Dr. Agarwal has stock in Reviva Pharmaceuticals Hld. An immediate family member of Dr. Agarwal has stock in Immuneering Corp. An immediate family member of Dr. Agarwal has stock in Imunon Inc. An immediate family member of Dr. Agarwal has stock in Enlivex Therapeutics. An immediate family member of Dr. Agarwal has stock in Candel Therapeutics. An immediate family member of Dr. Agarwal has stock in Applied Digital Corp. An immediate family member of Dr. Agarwal has stock in Atai Life Sciences. An immediate family member of Dr. Agarwal has stock in Adma Biologics. The institution of Dr. Agarwal has received research support from Biogen . The institution of Dr. Agarwal has received research support from CHDI Foundation. The institution of Dr. Agarwal has received research support from Eli Lilly. The institution of Dr. Agarwal has received research support from MJ Fox. The institution of Dr. Agarwal has received research support from Roche . The institution of Dr. Agarwal has received research support from Supernus. The institution of Dr. Agarwal has received research support from Nova Nordisc. The institution of Dr. Agarwal has received research support from Inhibikase. The institution of Dr. Agarwal has received research support from Intracellular therapeurtics.
Felix Bischof Felix Bischof has nothing to disclose.
Barbara Borroni, MD Dr. Borroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alector. Dr. Borroni has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley.
Kenneth H. Fischbeck, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fischbeck has received research support from NINDS/NIH. Dr. Fischbeck has received intellectual property interests from a discovery or technology relating to health care. Dr. Fischbeck has a non-compensated relationship as a Scientific Review Board member with Kennedy's Disease Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Council member with Association Francaise contre les Myopathies that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Independent Review Committee member with Target ALS that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member, Musculoskeletal Diseases with Novartis that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Senior Clinical Consultant with n-Lorem Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Committee member with Stanford GNE myopathy program that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Hereditary Disease Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Packard Center for ALS Research that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a Scientific Advisory Board member with Huntington's Disease Society of America that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Fischbeck has a non-compensated relationship as a TACT review panel member with TREAT-NMD that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Antonella Alberici, MD No disclosure on file
Maria Behrens, MD, PhD No disclosure on file
Helmut Butzkueven, MD, MBBS Dr. Butzkueven has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oxford Health Policy Forum. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. The institution of Dr. Butzkueven has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Butzkueven has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase . The institution of Dr. Butzkueven has received research support from NHMRC. The institution of Dr. Butzkueven has received research support from Biogen. The institution of Dr. Butzkueven has received research support from Roche. The institution of Dr. Butzkueven has received research support from Novartis.
Edgardo Cristiano, MD Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Cristiano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
John W. Roberts, MD No disclosure on file
John D. Steeves, PhD No disclosure on file
Roscoe O. Brady, MD No disclosure on file
Roberto Del Bo, PhD No disclosure on file
Karen A. Dellinger, MD No disclosure on file
Pierre Duquette, MD The institution of Dr. Duquette has received research support from Biogen and Genzyme.
Christine Klein, MD Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Centogene and Retromer Therapeutics. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Mov Disord, Ann Neurol, Science Adv. The institution of Dr. Klein has received research support from Centogene. Dr. Klein has received publishing royalties from a publication relating to health care.
Annika Berger, MD No disclosure on file
Gregory S. Aaen, MD Dr. Aaen has nothing to disclose.
Simon Cronin, PhD Prof. Cronin has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Bruce H. Dobkin, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Chiara Agosti, MD No disclosure on file
Roberto Bergamaschi Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Roberto Bergamaschi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi.
Chiara Briani, MD Dr. Briani has nothing to disclose.
Ana Djarmati, PhD No disclosure on file
Gisa Ellrichmann No disclosure on file
Chiara Fenoglio, PhD No disclosure on file
Michael Wong, MD, PhD No disclosure on file
Douglas L. Arnold, MD, FÂ鶹´«Ã½Ó³»­ Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Nicolas Dupre, MD, FÂ鶹´«Ã½Ó³»­ Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Eric Edgar, MD No disclosure on file
Shlomo Flechter, MD, FÂ鶹´«Ã½Ó³»­ Dr. Flechter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Flechter has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma.
Daniela Galimberti, PhD No disclosure on file
Ahm M. Huq, MBBS, PhD Dr. Huq has nothing to disclose.
David S. Lynch, MBBS, PhD Dr. Lynch has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vigil Neuroscience. Dr. Lynch has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. The institution of Dr. Lynch has received research support from Ionis.
Tai-Seung Nam, MD No disclosure on file
Amit Bar-Or, MD, FRCPC Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merk/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving as a Consultant for cabaletta. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/EMD Serono. Dr. Bar-Or has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. The institution of Dr. Bar-Or has received research support from Novartis. The institution of Dr. Bar-Or has received research support from Biogen. The institution of Dr. Bar-Or has received research support from Roche/Genentech.
Walter O. Arruda, MD, PhD Dr. Arruda has nothing to disclose.
Brenda L. Banwell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Banwell has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Banwell has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Banwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Banwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Banwell has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Banwell has received research support from National MS Society. The institution of Dr. Banwell has received research support from NIH.
Darryl C. De Vivo, MD, FÂ鶹´«Ã½Ó³»­ Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen and Novartis. Dr. De Vivo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Aspa Therapeutics.
Gereon Fink No disclosure on file
Ichiro Miyai, MD, PhD No disclosure on file
Karen E. Morrison, PhD, FRCP No disclosure on file
Noriaki Hattori, MD, PhD No disclosure on file
Mark R. Hurtt, MD No disclosure on file
Pankhil Shah No disclosure on file
Evgeny Sidorov, MD Dr. Sidorov has nothing to disclose.
Andrew Singleton An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care.
Margaret M. Timmons, MD No disclosure on file
Cyrus P. Zabetian, MD The institution of Dr. Zabetian has received research support from American Parkinson Disease Association. The institution of Dr. Zabetian has received research support from Department of Veterans Affairs. The institution of Dr. Zabetian has received research support from NIH. Dr. Zabetian has a non-compensated relationship as a Member, Scientific Advisory Council with Lewy Body Dementia Association that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Rosa Capozzo No disclosure on file
Edite Rio, MD No disclosure on file
Susanne Steinlechner No disclosure on file
Oivind Torkildsen No disclosure on file
Philippe Cabre, MD No disclosure on file
Ruediger Hilker, MD No disclosure on file
Chunfeng Liu No disclosure on file
Abdul Malik, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Sandipan Pati, MD Dr. Pati has nothing to disclose.
Emily K. Plowman-Prine, PhD No disclosure on file
Istvan Pirko, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Nicolaas I. Bohnen, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Bohnen has stock in Delta. The institution of Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from VA. Dr. Bohnen has received research support from NIH. The institution of Dr. Bohnen has received research support from Parkinson fnd.
Simona Bonavita No disclosure on file
Emmanuel Carrera No disclosure on file
Michel Chofflon, MD No disclosure on file
Facundo Manes No disclosure on file
Luisa Rojas, MD No disclosure on file
Stewart A. Factor, DO, FÂ鶹´«Ã½Ó³»­ Dr. Factor has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Neurocrine. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Factor has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. The institution of Dr. Factor has received research support from Biohaven. The institution of Dr. Factor has received research support from Neurocrine. The institution of Dr. Factor has received research support from Supernus. The institution of Dr. Factor has received research support from Sun Pharmaceuticals Advanced Research Company. The institution of Dr. Factor has received research support from Aspen. The institution of Dr. Factor has received research support from RHO. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care. Dr. Factor has received publishing royalties from a publication relating to health care.
Nereo Bresolin, DR No disclosure on file
Norbert Bruggemann, MD No disclosure on file
Detlef Claus, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Roderic H. Fabian, MD No disclosure on file
Isabella Ghione No disclosure on file
Alida F. Griffith, MD No disclosure on file
Brian C. Healy The institution of Mr. Healy has received research support from Analysis Group. The institution of Mr. Healy has received research support from Bristol-Myers Squibb. The institution of Mr. Healy has received research support from Verily Life Sciences. The institution of Mr. Healy has received research support from Novartis. The institution of Mr. Healy has received research support from Merck Serono. The institution of Mr. Healy has received research support from Genzyme.
Donald S. Higgins, Jr., MD, FÂ鶹´«Ã½Ó³»­ Dr. Higgins has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vaccinex.
Andrea Martinuzzi, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Talip Asil, MD No disclosure on file
Todd D. Levine, MD Dr. Levine has received personal compensation for serving as an employee of CND life sciences . Dr. Levine has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Nufactor. Dr. Levine has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for PNA. Dr. Levine has or had stock in CND Life Sciences.Dr. Levine has or had stock in Corinthian reference lab.
Ralf Gold, MD Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen . Dr. Gold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer Vital. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai Pharamaceuticals. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Gold has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis. Dr. Gold has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Biogen. The institution of Dr. Gold has received research support from Novartis. The institution of Dr. Gold has received research support from Biogen.
Sandra Magalhaes No disclosure on file
Michelangelo Mancuso, MD No disclosure on file
Henry F. McFarland, MD Dr. McFarland has received intellectual property interests from a discovery or technology relating to health care. Dr. McFarland has received personal compensation in the range of $50,000-$99,999 for serving as a Medical Director with Cumming Foundation.
Corey McMillan, PhD Dr. McMillan has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. McMillan has received research support from Biogen. The institution of Dr. McMillan has received research support from NIH.
John Shoffner IV, MD No disclosure on file
Maria Trojano Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi_Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi-Genzyme. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Maria Trojano has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen.
Rhonda Voskuhl, MD Dr. Voskuhl has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for CleopatraRX. Dr. Voskuhl has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for CleopatraRX. Dr. Voskuhl has or had stock in CleopatraRX. The institution of Dr. Voskuhl has received research support from NIH. The institution of Dr. Voskuhl has received research support from Conrad N Hilton Foundation. Dr. Voskuhl has received intellectual property interests from a discovery or technology relating to health care.
Stig Wergeland, MD, PhD Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wergeland has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi. Dr. Wergeland has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Wergeland has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. The institution of Dr. Wergeland has received research support from Biogen.
James Y. Garbern, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Ali Samii, MD, FRCP Dr. Samii has nothing to disclose.
Tanuja Chitnis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Chitnis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche-Genentech. Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave Biosciences. Dr. Chitnis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. The institution of Dr. Chitnis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Chitnis has received research support from Novartis. The institution of Dr. Chitnis has received research support from Sanofi. The institution of Dr. Chitnis has received research support from Octave. The institution of Dr. Chitnis has received research support from Genentech-Roche. The institution of Dr. Chitnis has received research support from Tiziana Life Sciences. The institution of Dr. Chitnis has received research support from Bristol-Myers Squibb. The institution of Dr. Chitnis has received research support from Wesley Clover.
Robert H. Brown, Jr., MD, DPhil Dr. Brown has received personal compensation for serving as an employee of ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for ApicBio. Dr. Brown has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Warren Alpert Foundation. Dr. Brown has stock in ApicBio. Dr. Brown has stock in Amylx. Dr. Brown has stock in Imstar. The institution of Dr. Brown has received research support from Angel Fund for ALS Research. The institution of Dr. Brown has received research support from ALS Association. The institution of Dr. Brown has received research support from ALSOne. The institution of Dr. Brown has received research support from NINDS. The institution of Dr. Brown has received research support from ALS Finding A Cure. Dr. Brown has received publishing royalties from a publication relating to health care.
Marcela Fiol Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for merck. The institution of Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Merck. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Teva. Marcela Fiol has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Roche.
Mark Gorman, MD The institution of Dr. Gorman has received research support from Pfizer. The institution of Dr. Gorman has received research support from Roche / Genetech .
Genevieve Langley No disclosure on file
Helmi L. Lutsep, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lutsep has received personal compensation in the range of $0-$499 for serving as a Consultant for Abbott. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lutsep has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Coherex Medical. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NINDS/Mayo Cinic. Dr. Lutsep has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medscape Neurology.
Jacqueline Montes, PT, EdD, NCS Ms. Montes has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for F. Hoffman LaRoche. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. Ms. Montes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. The institution of Ms. Montes has received research support from NIH/NICHD. The institution of Ms. Montes has received research support from Muscular Dystrophy Association. The institution of Ms. Montes has received research support from Cure SMA.
Massimo Pandolfo, MD, FÂ鶹´«Ã½Ó³»­ Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Design Therapeutics . Dr. Pandolfo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Solid Bio. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Design Therapeutics. Dr. Pandolfo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Larimar. Dr. Pandolfo has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Genetics. Dr. Pandolfo has stock in Voyager Therapeutics. The institution of Dr. Pandolfo has received research support from Freidreich Ataxaia Research Alliance. Dr. Pandolfo has a non-compensated relationship as a Scientific Advisory Board with Friedreich Ataxia Research Alliance that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Pandolfo has a non-compensated relationship as a Member-Meeting Management Committee with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Yahya Celik, MD No disclosure on file
Stefania Corti, MD, PhD Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Corti has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Corti has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta.
Barbara S. Giesser, MD, FÂ鶹´«Ã½Ó³»­ Dr. Giesser has received publishing royalties from a publication relating to health care. Dr. Giesser has a non-compensated relationship as a advisory committee member with National MS Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Felicia Goldstein No disclosure on file
Orla Gray, MD Dr. Gray has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Gray has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Gray has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for MSBase.
Heather Hanwell, PhD No disclosure on file
Laura Herbelin No disclosure on file
Melissa McGowan No disclosure on file
David Orion No disclosure on file
Alison Goate, PhD No disclosure on file
Nicole C. Hank, MCR, MHSM No disclosure on file
Hojoong Kim, MD No disclosure on file
Lisa R. Merlin, MD, FÂ鶹´«Ã½Ó³»­ Dr. Merlin has nothing to disclose.
Aldo A. Savino, MD No disclosure on file
Elio A. Scarpini, MD No disclosure on file
Mark A. Paine, MD, MBBS, FRACP No disclosure on file
Michel T. Torbey, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Torbey has nothing to disclose.
Guy A. Rouleau, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Rouleau has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NovoNordisk. Dr. Rouleau has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for AL-S Pharma.
Gabriele Siciliano Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Open Health. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Takeda. Gabriele Siciliano has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL Behring. Gabriele Siciliano has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Grifols. The institution of Gabriele Siciliano has received research support from Biogen.
Ely S. Simon, MD No disclosure on file
Teesta B. Soman, MD, MBBS No disclosure on file
Nikita Tangella No disclosure on file
Cinzia Gellera, MD No disclosure on file
Antoine Gueguen, MD An immediate family member of Dr. Gueguen has received personal compensation for serving as an employee of ABBVIE. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ALEXION. Dr. Gueguen has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Jonhson&Jonhson. Dr. Gueguen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Johnson&Johnson. The institution of Dr. Gueguen has received research support from BrainEver. The institution of Dr. Gueguen has received research support from Pixyl. The institution of Dr. Gueguen has received research support from Kalsiom. The institution of Dr. Gueguen has received research support from Ministére de la Santé, France.
Aissatou Haman No disclosure on file
Antonio Russo, Prof No disclosure on file
Holly A. Shill, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sage Biogen. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for KeifeRx. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Praxis Precision Medicine. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Fasikl Inc. Dr. Shill has received personal compensation in the range of $0-$499 for serving as a Consultant for Boston Scientific. Dr. Shill has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America.
Nicola Ticozzi, MD The institution of Dr. Ticozzi has received research support from Italian Ministry of Health . The institution of Dr. Ticozzi has received research support from AriSLA.
Benjamin G. Zifkin, MD No disclosure on file
Renato Colamarino, MD No disclosure on file
Aaron J. Johnson No disclosure on file
Klaus Lehmann-Horn, MD No disclosure on file
John Oakley, MD, PhD No disclosure on file
Joseph F. Quinn, MD, FÂ鶹´«Ã½Ó³»­ Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Disease Cooperative Study. Dr. Quinn has received personal compensation in the range of $500-$4,999 for serving as a DSMB with Alzheimer's Therapeutic Research Institute. Dr. Quinn has a non-compensated relationship as a consultant with Cognition Therapeutics that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Michael J. Reding, MD No disclosure on file
Louise R. Rodino-Klapac Ms. Rodino-Klapac has received personal compensation for serving as an employee of Sarepta Therapeutics, Inc.. Ms. Rodino-Klapac has received stock or an ownership interest from Sarepta Therapeutics. Ms. Rodino-Klapac has received intellectual property interests from a discovery or technology relating to health care.
Marwan N. Sabbagh, MD, FÂ鶹´«Ã½Ó³»­ Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eisai. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genetech=Roche. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novo Nordisk. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lilly. Dr. Sabbagh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Synaptogenix. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Signant Health. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Anavex. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cognito Therapeutics. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Sabbagh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Sabbagh has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for CervoMed. Dr. Sabbagh has stock in Neurotau. Dr. Sabbagh has stock in Seq Biomarque. Dr. Sabbagh has stock in uMethod Health. Dr. Sabbagh has stock in Athira. Dr. Sabbagh has stock in Lighthouse Pharmaceuticals. Dr. Sabbagh has stock in Alzheon. The institution of Dr. Sabbagh has received research support from NIH. The institution of Dr. Sabbagh has received research support from ADDF.
Alan Tam No disclosure on file
Kanjana Unnwongse, MD No disclosure on file
Ricardo F. Allegri, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Allegri has nothing to disclose.
Marc Debouverie, MD Dr. Debouverie has nothing to disclose.
Francois Dubeau, MD Dr. Dubeau has nothing to disclose.
Gilles Edan, MD No disclosure on file
Ofira Einstein No disclosure on file
Brian K. Kaspar, PhD No disclosure on file
Jeffrey A. Kaye, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kaye has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Kaye has stock in Life Analytics. The institution of Dr. Kaye has received research support from NIH. The institution of Dr. Kaye has received research support from NSF. The institution of Dr. Kaye has received research support from AbbVie. Dr. Kaye has received intellectual property interests from a discovery or technology relating to health care.
Erik P. Pioro, MD, DPhil, FÂ鶹´«Ã½Ó³»­ Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avanir Pharmaceutical, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx Pharmaceuticals. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MT Pharma America, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for NeuroTherapia, Inc.. Dr. Pioro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT Pharma America, Inc..
Gioacchino Tedeschi, MD Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lilly. Dr. Tedeschi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis.
Ayman P. Tourbah No disclosure on file
K. Reed Clark, PhD No disclosure on file
Mustapha A. Ezzeddine, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Ezzeddine has received research support from NIH.
Matthew Farrer, MD No disclosure on file
Farrukh S. Khan, MD, MBBS No disclosure on file
Liliana B. Patrucco, MD Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Patrucco has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Novartis. Dr. Patrucco has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Biogen.
Innocenzo Rainero, MD, PhD No disclosure on file
Julie N. Thai No disclosure on file
Clover Youn, MD Dr. Youn has nothing to disclose.
Kurt Lindsay, MD No disclosure on file
Claudio Mariani, MD No disclosure on file
Arthur Melms, MD No disclosure on file
Isaac Naggar, MD No disclosure on file
Ruth-Ann Marrie, MD, PhD The institution of Dr. Marrie has received research support from CIHR. The institution of Dr. Marrie has received research support from MS Canada. The institution of Dr. Marrie has received research support from National MS Society. The institution of Dr. Marrie has received research support from Crohn's and Colitis Canada. The institution of Dr. Marrie has received research support from US Department of Defense. The institution of Dr. Marrie has received research support from The Arthritis Society. The institution of Dr. Marrie has received research support from CMSC.
Joab Chapman, MD, PhD Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Mapi Pharma. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Chapman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merk Serono. The institution of Dr. Chapman has received research support from Ministry Of Industry.
Wayne M. Clark, MD Dr. Clark has nothing to disclose.
Francis J. DiMario, Jr., MD No disclosure on file
Sally Dunaway, DPT Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche/Genentech. Dr. Dunaway has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Scholar Rock. Dr. Dunaway has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Cure SMA. The institution of Dr. Dunaway has received research support from Cure SMA. The institution of Dr. Dunaway has received research support from Scholar Rock. The institution of Dr. Dunaway has received research support from Ionis Pharmaceuticals.
Charles R. Guttmann Charles R.G. Guttmann has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sintetica SA. Charles R.G. Guttmann has received stock or an ownership interest from Alnylam. Charles R.G. Guttmann has received stock or an ownership interest from Roche. Charles R.G. Guttmann has received stock or an ownership interest from Novartis. Charles R.G. Guttmann has received stock or an ownership interest from Arrowhead Pharmaceuticals. Charles R.G. Guttmann has received stock or an ownership interest from Protalix. Charles R.G. Guttmann has received stock or an ownership interest from Promethee. Charles R.G. Guttmann has received stock or an ownership interest from GSK. Charles R.G. Guttmann has received stock or an ownership interest from Sangamo. Charles R.G. Guttmann has received stock or an ownership interest from Alcon. Charles R.G. Guttmann has received stock or an ownership interest from Cocrystal Pharma. The institution of Charles R.G. Guttmann has received research support from NIH. The institution of Charles R.G. Guttmann has received research support from McGill University. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from BrightFocus Foundation. The institution of Charles R.G. Guttmann has received research support from National Multiple Sclerosis Society. The institution of Charles R.G. Guttmann has received research support from University of Connecticut Health Center. The institution of Charles R.G. Guttmann has received research support from U.S. Office of Naval Research.
Lauren C. Hyams, PhD No disclosure on file
Melanie Knight, PhD No disclosure on file
De-Hyung Lee, MD No disclosure on file
Ralf Linker Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
Masahito Mihara, MD, PhD No disclosure on file
Megan Montgomery No disclosure on file
Guillermo Izquierdo Ayuso, MD Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Jean P. Julien, PhD, BSC No disclosure on file
Thomas A. Kent, MD No disclosure on file
Fernando Kok, MD No disclosure on file
Haydeh Payami, PhD No disclosure on file
Thor Petersen No disclosure on file
Hartwig Siebner, MD No disclosure on file
David Tanne, MD No disclosure on file
Dora Yearout The institution of Dora Yearout has received research support from Veterans Affairs, NIH, and MJFF reserach grants.
John S. Romine, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Paul Valdmanis No disclosure on file
Vincent Van Pesch, MD, PhD Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Vincent Van Pesch, MD, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. The institution of Vincent Van Pesch, MD, PhD has received research support from Biogen.
Hamza I. Maqsood, MD Dr. Qureshi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for AstraZeneca.
George Grossberg, MD Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioXcel. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Karuna. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Maplight Therapeutics. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Otsuka. Dr. Grossberg has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Anavex. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Newron. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Oligomerix. The institution of Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Quince. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Dr. Grossberg has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Otsuka. The institution of Dr. Grossberg has received research support from NIA. The institution of Dr. Grossberg has received research support from Functional Neuromodulation .
Dina R. Amrom, MD No disclosure on file
Rana Assouad, MD No disclosure on file
Staley A. Brod, MD Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Brod has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi.
Margherita Ferrero No disclosure on file
Olivier F. Gout, MD Dr. Gout has nothing to disclose.
Randolph S. Marshall, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Marshall has received research support from NIH. Dr. Marshall has received publishing royalties from a publication relating to health care.
John W. Miller, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Stephanie Pinz No disclosure on file
Michael D. Geschwind, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Brainstorm Cell Therapeutics, Inc.. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Walter Grubb. Dr. Geschwind has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Geschwind has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Reata Pharmaceuticals, Inc..
Zohar Argov, MD No disclosure on file
Sun Ju Chung, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Chung has nothing to disclose.
Michael J. Doherty, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Bertrand Fontaine, MD No disclosure on file
Patrick Hautecoeur No disclosure on file
Petr Kanovsky, PhD Dr. Kanovsky has nothing to disclose.
Silke Schmidt, PhD No disclosure on file
David R. Beers, PhD No disclosure on file
Mouhammed R. Kabbani, MD No disclosure on file
Jayne Ness, MD An immediate family member of Dr. Ness has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jan One. The institution of Dr. Ness has received research support from Chugai/Roche. The institution of Dr. Ness has received research support from National Multiple Sclerosis Society. The institution of an immediate family member of Dr. Ness has received research support from NIH. An immediate family member of Dr. Ness has received publishing royalties from a publication relating to health care.
Sindhu R. Srivatsal, MD Dr. Srivatsal has nothing to disclose.
Tarek Zakaria, MD Dr. Zakaria has nothing to disclose.
Joshua Bacon, PhD No disclosure on file
Benjamin R. Brooks, MD, FÂ鶹´«Ã½Ó³»­ Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with Â鶹´«Ã½Ó³»­ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Anne H. Cross, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech / F. Hoffman la Roche. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb . Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octave. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Cross has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Cross has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Consortium of MS Centers. Dr. Cross has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Cross has received research support from Genentech. Dr. Cross has received intellectual property interests from a discovery or technology relating to health care.
Federica Esposito Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Merck. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Federica Esposito has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. The institution of Federica Esposito has received research support from Italian MS Society. The institution of Federica Esposito has received research support from Italian Ministry of Health. The institution of Federica Esposito has received research support from ERA Net. The institution of Federica Esposito has received research support from European Commission. Federica Esposito has received intellectual property interests from a discovery or technology relating to health care.
Ilya Kister, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kister has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech-Roche. Dr. Kister has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Horizon. The institution of Dr. Kister has received research support from Genentech. The institution of Dr. Kister has received research support from Novartis. Dr. Kister has received publishing royalties from a publication relating to health care.
Enrico Millefiorini No disclosure on file
Tsutomu Nakada, MD, PhD No disclosure on file
Claude G. Wasterlain, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Wasterlain has received research support from Eisai. Dr. Wasterlain has received publishing royalties from a publication relating to health care.
Thomas J. Montine, MD, PhD Dr. Montine has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Enable Medicine. Dr. Montine has stock in Enable Medicine. The institution of Dr. Montine has received research support from NIH. The institution of Dr. Montine has received research support from MJFF. Dr. Montine has received intellectual property interests from a discovery or technology relating to health care. Dr. Montine has received publishing royalties from a publication relating to health care.
Carsten Eggers No disclosure on file
Nancy R. Foldvary-Schaefer, DO, FÂ鶹´«Ã½Ó³»­ Dr. Foldvary-Schaefer has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Jazz. The institution of Dr. Foldvary-Schaefer has received research support from Suven. The institution of Dr. Foldvary-Schaefer has received research support from Takeda. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care. Dr. Foldvary-Schaefer has received publishing royalties from a publication relating to health care.
Nathalie M. Goemans, MD Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pfizer. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Goemans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Goemans has received publishing royalties from a publication relating to health care.
Qaisar A. Shah, MD No disclosure on file
Alessandro Tessitore Alessandro Tessitore has nothing to disclose.
Heidi Munger Clary, MD, MPH Dr. Munger Clary has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Xenon. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Prova Â鶹´«Ã½Ó³»­. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia Open. Dr. Munger Clary has stock in HCA Healthcare. Dr. Munger Clary has stock in Eli Lilly. Dr. Munger Clary has stock in Procter and Gamble. Dr. Munger Clary has stock in CVS. Dr. Munger Clary has stock in Johnson and Johnson. Dr. Munger Clary has stock in Novartis. Dr. Munger Clary has stock in Danahauer. The institution of Dr. Munger Clary has received research support from National Institute of Health. The institution of Dr. Munger Clary has received research support from Suzanne Marcus Collins Foundation. The institution of Dr. Munger Clary has received research support from Eysz, Inc. The institution of Dr. Munger Clary has received research support from Department of Defense. The institution of Dr. Munger Clary has received research support from Duke Endowment. Dr. Munger Clary has received personal compensation in the range of $500-$4,999 for serving as a speaker, Psychiatry Commission member with International League Against Epilepsy. Dr. Munger Clary has received personal compensation in the range of $0-$499 for serving as a Faculty with J. Kiffin Penry Epilepsy Â鶹´«Ã½Ó³»­ Programs. Dr. Munger Clary has a non-compensated relationship as a advisor, potential site PI with Liva Nova that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Sarah Carr No disclosure on file
Alfredo Damasceno, MD No disclosure on file
Jia Huang, MD No disclosure on file
Arnaud Lacour No disclosure on file
Brett Monia, PhD No disclosure on file
Fabienne M. Perren, MD No disclosure on file
Nara Chhua No disclosure on file
Joseph Herbert, MD No disclosure on file
Masatoyo Nishizawa, MD No disclosure on file
Joan Severson No disclosure on file
Elson L. So, MD, FÂ鶹´«Ã½Ó³»­ Dr. So has nothing to disclose.
David Baker No disclosure on file
Valentina Durastanti, MD No disclosure on file
Steven Flanagan, PhD No disclosure on file
Gavin Giovannoni, MD Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Max J. Hilz, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Hilz has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for SANOFI. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Hilz has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Terrence D. Lagerlund, MD, PhD Dr. Lagerlund has nothing to disclose.
Sarah Ryan No disclosure on file
Saud Sadiq, BS, FÂ鶹´«Ã½Ó³»­ Ms. Brewi has nothing to disclose.
Norbert Sommer, MD No disclosure on file
Amie L. Hiller, MD The institution of Dr. Hiller has received research support from Admas Pharmaceuticals.
Alain Creange Alain Creange has nothing to disclose.
Daria Dinacci No disclosure on file
Anna Jurewicz, MD No disclosure on file
Lydia C. Kwee, PhD No disclosure on file
Wei-Dong Le, MD, PhD No disclosure on file
Timothy Lesnick No disclosure on file
Leonardo Lopez, MD No disclosure on file
Juan Carlos Muniz, MD No disclosure on file
Preetha Muthusamy, MD No disclosure on file
Shin J. Oh, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Antonia Ratti, PhD No disclosure on file
Edward C. Smith, MD Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity Biosciences. Dr. Smith has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Solid Bioscences. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst.
Tim Wehner, MD No disclosure on file
Jean-Pierre Bouchard, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Elise Caccappolo No disclosure on file
Laura Marsh, MD No disclosure on file
Cynthia L. Comella, MD, FÂ鶹´«Ã½Ó³»­ Dr. Comella has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Ipsen. Dr. Comella has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vima. Dr. Comella has received publishing royalties from a publication relating to health care. Dr. Comella has received publishing royalties from a publication relating to health care.
Steven W. Anderson, PhD Dr. Anderson has nothing to disclose.
Stanley H. Appel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Appel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Pharma. Dr. Appel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Eledon. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Implicit. The institution of Dr. Appel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Coya Therapeutics. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Muscular Disease Association. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Therapy Development Institute. Dr. Appel has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for ALS Finding a Cure. Dr. Appel has stock in Stock holdings in retirement acct at Fidelity. The institution of Dr. Appel has received research support from Coya Therapeutics.
Sergio J. Gonzalez No disclosure on file
Andrea L. Gropman, MD, FÂ鶹´«Ã½Ó³»­ Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Baylor Mirica. Dr. Gropman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Immedica. Dr. Gropman has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for various legal firms. The institution of Dr. Gropman has received research support from National Institutes of Health.
Wolfgang Singer, MD, FÂ鶹´«Ã½Ó³»­ Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. The institution of Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ionis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Yoda. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theravance. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ferrer. The institution of Dr. Singer has received research support from NIH. The institution of Dr. Singer has received research support from FDA. The institution of Dr. Singer has received research support from Michael J. Fox Foundation. Dr. Singer has received intellectual property interests from a discovery or technology relating to health care.
Beth Wilmot, MS No disclosure on file
Richard B. Lipton, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. Dr. Lipton has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lundbeck. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GlaxoSmithKline. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teva. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vedanta. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Grifols. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axon. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Satsuma. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Cool Tech. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BDSI. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Clexio. Dr. Lipton has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shiratronics. Dr. Lipton has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan/Abbvie. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly. Dr. Lipton has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. Dr. Lipton has or had stock in Biohaven.Dr. Lipton has or had stock in Manistee.Dr. Lipton has or had stock in Axon.Dr. Lipton has or had stock in CoolTech. The institution of Dr. Lipton has received research support from Teva. The institution of Dr. Lipton has received research support from Amgen. The institution of Dr. Lipton has received research support from Allergan/Abbvie. The institution of Dr. Lipton has received research support from Gammacore. The institution of Dr. Lipton has received research support from Axsome. The institution of Dr. Lipton has received research support from Charleston Labs. The institution of Dr. Lipton has received research support from Eli Lilly. The institution of Dr. Lipton has received research support from Satsuma. The institution of Dr. Lipton has received research support from NIH . The institution of Dr. Lipton has received research support from Veterans Administration. Dr. Lipton has received publishing royalties from a publication relating to health care.
Chizuru Akimoto, MD No disclosure on file
Harry Chugani, MD No disclosure on file
Violaine K. Harris, PhD No disclosure on file
Jenny Henkel, PhD No disclosure on file
Junaid Kalia, MD No disclosure on file
Aparna Komatineni, MD No disclosure on file
Juan Ignacio Rojas, MD Dr. Rojas has nothing to disclose.
Michael S. Okun, MD, FÂ鶹´«Ã½Ó³»­ Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Scott S. Zamvil, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Genzyme. Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Horizon. The institution of Dr. Zamvil has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. The institution of Dr. Zamvil has received research support from Sumaira Foundation. Dr. Zamvil has received personal compensation in the range of $5,000-$9,999 for serving as a Advisory Board with Genzyme. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Genentech. Dr. Zamvil has received personal compensation in the range of $500-$4,999 for serving as a Advisory Board with Alexion.
Demetrius M. Maraganore, MD, FÂ鶹´«Ã½Ó³»­ Dr. Maraganore has nothing to disclose.
Florent Borgel, MD No disclosure on file
John N. Caviness, MD, FÂ鶹´«Ã½Ó³»­ Dr. Caviness has nothing to disclose.
Raymond T. Cheung, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Terry D. Heiman-Patterson, MD Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for MTPA. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Heiman-Patterson has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Dr. Heiman-Patterson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for biogen. The institution of Dr. Heiman-Patterson has received research support from MTPA. The institution of Dr. Heiman-Patterson has received research support from State of Pennsylvania . The institution of Dr. Heiman-Patterson has received research support from ALS Association. The institution of Dr. Heiman-Patterson has received research support from ALS United. The institution of Dr. Heiman-Patterson has received research support from ALS Hope Foundation.
Letizia Mazzini No disclosure on file
Richard M. Tsai, MD Dr. Tsai has received personal compensation for serving as an employee of Denali Therapeutics. Dr. Tsai has stock in Denali Therapeutics.
Giovanna Vaula, MD No disclosure on file
Elan D. Louis, MD, MS, FÂ鶹´«Ã½Ó³»­ Dr. Louis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer - Merritt's Textbook of Neurology. Dr. Louis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Legal Firm. The institution of Dr. Louis has received research support from National Institutes of Health. Dr. Louis has received publishing royalties from a publication relating to health care. Dr. Louis has a non-compensated relationship as a Board of Directors with International Essential Tremor Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Louis has a non-compensated relationship as a Medical Advisory Board with HopeNET that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Andrew D. Siderowf, MD Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boehringer-Ingelheim. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for askbio. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for capsida. Dr. Siderowf has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Parkinson Study Group. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theravance. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prilenia. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Wave. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Neurogastrix. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Prevail. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alerity. Dr. Siderowf has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Clintrex. Dr. Siderowf has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. Dr. Siderowf has a non-compensated relationship as a Scientific Advisory Board with NeuroPacs that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Frederic Blanc No disclosure on file
Amy Colcher, MD No disclosure on file
Cristina Costa, MD No disclosure on file
Nancy L. Kuntz, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenyx. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Audentes Therapeutics. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Kuntz has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Kuntz has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Kuntz has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Scholar Rock. The institution of Dr. Kuntz has received research support from Argenx. The institution of Dr. Kuntz has received research support from Astellas. The institution of Dr. Kuntz has received research support from Biogen. The institution of Dr. Kuntz has received research support from Catalyst. The institution of Dr. Kuntz has received research support from Genentech. The institution of Dr. Kuntz has received research support from Scholar Rock. The institution of Dr. Kuntz has received research support from Regenx-Bio. The institution of Dr. Kuntz has received research support from Solid Biosciences. The institution of Dr. Kuntz has received research support from AMO. The institution of Dr. Kuntz has received research support from Novartis. The institution of Dr. Kuntz has received research support from BioHaven. Dr. Kuntz has received personal compensation in the range of $50,000-$99,999 for serving as a Sarepta Express post gene therapy advisor with Sarepta.
Joy B. Parrish An immediate family member of Ms. Parrish has received personal compensation for serving as an employee of DPK Technology. Ms. Parrish has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National football league. Ms. Parrish has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for National Hockey League.
Barry Byrne Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rocket Pharma. Barry Byrne has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Muscular Dystrophy Association.
Daniel Mielcarz No disclosure on file
Davide Pareyson, MD No disclosure on file
Guillaume Sebire No disclosure on file
Fu-Dong Shi, MD, PhD No disclosure on file
Daniel Becker, MD Dr. Becker has nothing to disclose.
Faisal Fecto, MD, PhD The institution of Dr. Fecto has received research support from NINDS.
Harry M. Koslowski, MD No disclosure on file
Luanne Metz, MD The institution of Dr. Metz has received research support from Multiple Sclerosis Society of Canada. The institution of Dr. Metz has received research support from Calgary Health Trust. The institution of Dr. Metz has received research support from Government of Alberta.
Carolyn F. Orr, MD No disclosure on file
Xiomara Q. Rosales, MD No disclosure on file
Joshua M. Shulman, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Shulman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Helis Medical Foudation. The institution of Dr. Shulman has received research support from National Institutes of Health.
Sandro Sorbi Sandro Sorbi has nothing to disclose.
Kerry Thompson No disclosure on file
Mitsuya Morita, MD, PhD Dr. Morita has nothing to disclose.
Imaharu Nakano, MD No disclosure on file
Stefan Nessler, MD No disclosure on file
Wolfgang H. Oertel, MD, FÂ鶹´«Ã½Ó³»­ Dr. Oertel has received personal compensation for serving as an employee of ParkinsonFonds Deutschland. Dr. Oertel has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for IntraBio, UK. Dr. Oertel has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for MODAG Germany. The institution of Dr. Oertel has received research support from Stichting ParkinsonFonds, The Netherlands,. The institution of Dr. Oertel has received research support from Michael J Fox Foundation.
Frances Roberts No disclosure on file
Lucie Suchomelova No disclosure on file
Kwok-Keung Tai No disclosure on file
Bruce L. Miller, MD, FÂ鶹´«Ã½Ó³»­ Dr. Miller has nothing to disclose.
Carol F. Lippa, MD Dr. Lippa has nothing to disclose.
Selim R. Benbadis, MD, FÂ鶹´«Ã½Ó³»­ Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Stratus. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for SK Lifesciences. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Jazz. Dr. Benbadis has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Catalyst. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Neurelis. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sunovion. Dr. Benbadis has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Livanova. Dr. Benbadis has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for UCB.
David Skoloudik, MD, PhD No disclosure on file
Michel G. Clanet, Prof No disclosure on file
Antonio Federico, MD, Prof No disclosure on file
Sotirios Giannopoulos, MD No disclosure on file
Luigi Lavorgna No disclosure on file
Christine Lebrun Frenay, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lebrun Frenay has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Revue Neurologique. The institution of Dr. Lebrun Frenay has received research support from FRANCE SEP.
Liang Lu, MD, FÂ鶹´«Ã½Ó³»­ Dr. Lu has nothing to disclose.
Franco Taroni, MD The institution of Dr. Taroni has received research support from Italian Ministry of Health. The institution of Dr. Taroni has received research support from Fondazione Regionale per la Ricerca Biomedica.
Herilavitra Ratinahirana, MD No disclosure on file
Steven Frucht, MD Dr. Frucht has nothing to disclose.
Emmanuelle Waubant, MD, PhD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Waubant has received research support from NIH. The institution of Dr. Waubant has received research support from NMSS. The institution of Dr. Waubant has received research support from PCORI. The institution of Dr. Waubant has received research support from Race to Erase MS. The institution of Dr. Waubant has received research support from Roche. The institution of Dr. Waubant has received research support from Department of Defense. Dr. Waubant has received publishing royalties from a publication relating to health care.
Sergiu C. Blumen, MD No disclosure on file
Marie-Emmanuelle Dilenge, MD No disclosure on file
Derya Kaya No disclosure on file
Janaiah Kota No disclosure on file
Joo Y. Kwon, MD No disclosure on file
Olivier Outteryck Olivier Outteryck has nothing to disclose.
Stanley Fahn, MD, FÂ鶹´«Ã½Ó³»­ Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Stoparkinson Healthcare Systems, LLC; . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Retrophin Inc . Dr. Fahn has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Publishers . Dr. Fahn has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Kirkland & Ellis. Dr. Fahn has received publishing royalties from a publication relating to health care.
Blair Ford, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Lorraine N. Clark, PhD No disclosure on file
Bertrand De Toffol, MD No disclosure on file
Baruch El-Ad, MD No disclosure on file
Roberta Lanzillo Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck, Biogen. Roberta Lanzillo has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen, Roche, Novartis.
Karen S. Marder, MD, MPH, FÂ鶹´«Ã½Ó³»­ Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Marder has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Parkinson's Foundation . Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CHDI. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC therapeutics. Dr. Marder has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer LTD. The institution of Dr. Marder has received research support from Vaccinex. The institution of Dr. Marder has received research support from Genentech. The institution of Dr. Marder has received research support from Triplet Therapeutics. The institution of Dr. Marder has received research support from Prilenia.
Francois Grand-Maison, MD Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Serono. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Grand-Maison has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis .
R.M.M. Hupperts, MD No disclosure on file
Jeannette Lechner-Scott, MD, PhD, FRACP The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. The institution of Prof. Lechner-Scott has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for elsevier. The institution of Prof. Lechner-Scott has received research support from Merck. The institution of Prof. Lechner-Scott has received research support from Biogen.
Kjell Morten Myhr, MD No disclosure on file
Yonas E. Geda, MD The institution of Dr. Geda has received research support from NIH. Dr. Geda has received intellectual property interests from a discovery or technology relating to health care.
Megumi Hatakenaka, MD No disclosure on file
Lynn Kataria, MD Dr. Kataria has nothing to disclose.
Rebekka Lencer No disclosure on file
Michaelangelo Fuortes No disclosure on file
Anne K. Grunewald, PhD No disclosure on file
Orla Hardiman, MD, DSc, FRCPI, MRIA, FÂ鶹´«Ã½Ó³»­ Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Wave Pharmaceuticals. Dr. Hardiman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cytokinetics . Dr. Hardiman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hardiman has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Taylor and Francis. The institution of Dr. Hardiman has received research support from Science Foundation Ireland. The institution of Dr. Hardiman has received research support from HRB.
Meike Kasten, MD No disclosure on file
Eliezer Masliah, MD Dr. Masliah has nothing to disclose.
Katherine E. Lewis, PhD Katherine E. Lewis, PhD has received personal compensation for serving as an employee of Alpine Immune Sciences. Katherine E. Lewis, PhD has stock in Alpine Immune Sciences.
Patricia Maciel, MD No disclosure on file
Sridar Narayanan Sridar Narayanan has received personal compensation for serving as an employee of NeuroRx Research. Sridar Narayanan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech Inc.. The institution of Sridar Narayanan has received research support from Immunotec Inc.
Robert L. Ruff, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Gregory A. Worrell, MD Dr. Worrell has received stock or an ownership interest from NeuroOne Inc.. Dr. Worrell has received stock or an ownership interest from Cadence Neuroscience Inc. The institution of Dr. Worrell has received research support from NIH. The institution of Dr. Worrell has received research support from Medtronic Inc.. The institution of Dr. Worrell has received research support from Neuropace Inc,. The institution of Dr. Worrell has received research support from Epilepsy Foundation of America. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care. Dr. Worrell has received intellectual property interests from a discovery or technology relating to health care.
Brendon Honick No disclosure on file
J. Douglas Miles, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx US, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB, Inc.. Dr. Miles has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals, Inc. . Dr. Miles has received research support from HMSA Center of Learning Innovation. Dr. Miles has received publishing royalties from a publication relating to health care.
John R. Rinker II, MD, BA Dr. Rinker has nothing to disclose.
Amitava Chakrabarti, MD, MBBS No disclosure on file
Megan Hyland, MD The institution of Dr. Hyland has received research support from Biogen. The institution of Dr. Hyland has received research support from PCORI.
Deniz Erten-Lyons, MD, FÂ鶹´«Ã½Ó³»­ Dr. Erten-Lyons has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia Pharamceuticals.
Christine Stadelmann-Nessler No disclosure on file
Adeline Vanderver, MD, FÂ鶹´«Ã½Ó³»­ An immediate family member of Dr. Vanderver has received personal compensation for serving as an employee of Maryland Physician Care. The institution of Dr. Vanderver has received research support from Takeda. The institution of Dr. Vanderver has received research support from Passage Bio. The institution of Dr. Vanderver has received research support from Homology. The institution of Dr. Vanderver has received research support from Eli Lilly. The institution of Dr. Vanderver has received research support from Myrtelle. The institution of Dr. Vanderver has received research support from SynaptixBio. The institution of Dr. Vanderver has received research support from PMD Foundation. The institution of Dr. Vanderver has received research support from Ionis. The institution of Dr. Vanderver has received research support from ISD . The institution of Dr. Vanderver has received research support from Boehringer-Ingelheim. The institution of Dr. Vanderver has received research support from Biogen. The institution of Dr. Vanderver has received research support from Sana. The institution of Dr. Vanderver has received research support from Affinia. The institution of Dr. Vanderver has received research support from BridgeBio. The institution of Dr. Vanderver has received research support from Orchard. The institution of Dr. Vanderver has received research support from Minoryx. The institution of Dr. Vanderver has received research support from Forge Biologics. The institution of Dr. Vanderver has received research support from Vigil. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care. Dr. Vanderver has received intellectual property interests from a discovery or technology relating to health care.
Margaret A. Pericak-Vance, PhD Dr. Pericak-Vance has nothing to disclose.
Ralph H. Benedict, PhD Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Benedict has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bristol Meyers Squibb. Dr. Benedict has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic Therapeutics. Dr. Benedict has received intellectual property interests from a discovery or technology relating to health care.
Han-Xiang Deng, MD Dr. Deng has nothing to disclose.
Danna L. Jennings, MD Dr. Jennings has received personal compensation for serving as an employee of Denali Therapeutics . Dr. Jennings has received stock or an ownership interest from Denali Therapeutics.
Vinod Malik No disclosure on file
Jeffrey C. McClean II, MD, FÂ鶹´«Ã½Ó³»­ Dr. McClean has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. McClean has received personal compensation in the range of $0-$499 for serving as a Committee Member with Â鶹´«Ã½Ó³»­.
Ruth Ottman, PhD No disclosure on file
Michael H. Rosenbloom, MD, FÂ鶹´«Ã½Ó³»­ Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Esai. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eisai. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Johnson and Johnson. Dr. Rosenbloom has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Medscape.
Claudio Solaro, MD No disclosure on file
Cheryl H. Waters, MD, FÂ鶹´«Ã½Ó³»­ Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Acadia. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kyowa. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexza. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acorda. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Acadia. Dr. Waters has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Neurocrine. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bial. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for US world meds. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lundbeck. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adamas. Dr. Waters has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sunovion. Dr. Waters has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal.
Bradley J. Katz, MD, PhD Bradley J. Katz, MD, PhD has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for axon optics, LLC. Bradley J. Katz, MD, PhD has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for self employed. Bradley J. Katz, MD, PhD has received stock or an ownership interest from Pfizer. Bradley J. Katz, MD, PhD has received intellectual property interests from a discovery or technology relating to health care.
Suzee Lee, MD Dr. Lee has nothing to disclose.
Denis Saudeau, MD No disclosure on file
Christopher J. Klein, MD, FÂ鶹´«Ã½Ó³»­ Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Khurram Bashir, MD The institution of Dr. Bashir has received research support from NIH. The institution of Dr. Bashir has received research support from PICORI. The institution of Dr. Bashir has received research support from Sanofi. Dr. Bashir has received research support from GWSP. The institution of Dr. Bashir has received research support from Roche. The institution of Dr. Bashir has received research support from Novartis. The institution of Dr. Bashir has received research support from Hoffmann-La Roche.
Ana Belen Caminero Rodriguez, MD Dr. Caminero Rodriguez has nothing to disclose.
Jorge D. Correale, MD Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ROche. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Correale has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Correale has received research support from Merck. The institution of Dr. Correale has received research support from Biogen. The institution of Dr. Correale has received research support from Novartis .
Simone Di Rezze No disclosure on file
Sha Mi, PhD No disclosure on file
Weihua Zhao, MD No disclosure on file
Kim Parker Gannon No disclosure on file
Matthew Rizzo, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Rizzo has received research support from NIH.
Shannon McWeeney No disclosure on file
Filippo Martinelli Boneschi No disclosure on file
Lloyd H. Kasper, MD No disclosure on file
Genevieve Bernard, MD Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Calico. Dr. Bernard has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Orchard Therapeutics. Dr. Bernard has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for N/A. The institution of Dr. Bernard has received research support from Canadian Institutes of Health Research. The institution of Dr. Bernard has received research support from Montreal Children's Foundation. The institution of Dr. Bernard has received research support from Yaya Foundation for 4H Leukodystrophy. The institution of Dr. Bernard has received research support from Fondation Les Amis d'Elliot. The institution of Dr. Bernard has received research support from Ionis. Dr. Bernard has a non-compensated relationship as a Member of the Scientific Advisory Board with Pelizaeus-Merzbacher Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Bernard has a non-compensated relationship as a Chair of the Medical and Scientific Advisory Board with United Leukodystrophy Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Bernard has a non-compensated relationship as a Member of the Scientific and Clinical advisory Council with Yaya Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Merrill Benson No disclosure on file
Denise I. Campagnolo, MD, MS Dr. Campagnolo has received personal compensation for serving as an employee of Biogen. Dr. Campagnolo has received stock or an ownership interest from Biogen.
Fernando Cendes, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB Biopharma. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for United Medical – Brazil. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Zodiac Pharma . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eurofarma – Brazil . Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Epilepsia. Dr. Cendes has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers in Neurology - Epilepsy. The institution of Dr. Cendes has received research support from São Paulo Research Foundation - FAPESP. The institution of Dr. Cendes has received research support from Conselho Nacional de Desenvolvimento Científico e Tecnológico - Brazil . The institution of Dr. Cendes has received research support from NIH.
Mel Feany, MD, PhD No disclosure on file
Deborah H. Hall, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Hall has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier - Parkinsonism and Related Disorders. Dr. Hall has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Annals of Neurology. The institution of Dr. Hall has received research support from Parkinson's Foundation. The institution of Dr. Hall has received research support from CHDI. The institution of Dr. Hall has received research support from Uniqure. The institution of Dr. Hall has received research support from NIH.
Ellen H. O'Donnell No disclosure on file
Menachem Sadeh, MD No disclosure on file
William K. Scott, MD No disclosure on file
Sibyl E. Wray, MD Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Heng Zhao, PhD No disclosure on file
Isabelle Bonnaud, MD No disclosure on file
Benedetta Nacmias Benedetta Nacmias has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier.
Pedro S. Oliveira, MD No disclosure on file
Christopher Walker, PhD No disclosure on file
Stephan Zuchner, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zuchner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Applied Therapeutics. The institution of Dr. Zuchner has received research support from Muscular Dystrophy Association. The institution of Dr. Zuchner has received research support from CMT Association. Dr. Zuchner has received intellectual property interests from a discovery or technology relating to health care.
Roby J. Abraham, MD No disclosure on file
Kyoung-Gyu Choi No disclosure on file
Paul J. Hagerman, MD, PhD No disclosure on file
Ronald F. Pfeiffer, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Christopher Shilling, MS No disclosure on file
Harry T. Whelan, MD No disclosure on file
Javier Ochoa-Reparaz, PhD No disclosure on file
Philip De Jager, MD, PhD Dr. De Jager has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Puretech. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for roche. Dr. De Jager has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for biogen. The institution of Dr. De Jager has received research support from roche. The institution of Dr. De Jager has received research support from puretech.
Reinhard Hohlfeld, MD Dr. Hohlfeld has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis .
Teepu Siddique, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Susan B. Bressman, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Bressman has received research support from Michael J Fox Foundation . The institution of Dr. Bressman has received research support from NIH .
Martha A. Nance, MD Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Voyager. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ROche. Dr. Nance has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. An immediate family member of Dr. Nance has received stock or an ownership interest from Fresca. The institution of Dr. Nance has received research support from HDSA. The institution of Dr. Nance has received research support from Parkinson Foundation. Dr. Nance has received research support from Parkinson Foundation. The institution of Dr. Nance has received research support from Neuraly. Dr. Nance has received personal compensation in the range of $500-$4,999 for serving as a speaker with Â鶹´«Ã½Ó³»­.
Brian D. Ross, MD No disclosure on file
Roy Alcalay, MD Dr. Alcalay has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genzyme/Sanofi. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gain Therapeutics. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vanqua Bio. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Capsida. Dr. Alcalay has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. The institution of Dr. Alcalay has received research support from Michael J. Fox Foundation. The institution of Dr. Alcalay has received research support from Parkinson's Foundation. The institution of Dr. Alcalay has received research support from Silverstein Foundation. Dr. Alcalay has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant with Parkinson's Foundation.
Lev Goldfarb, MD No disclosure on file
John W. McDonald III, MD, PhD No disclosure on file
Susan F. Mickel, MD No disclosure on file
Anamarli Nucci No disclosure on file
Charles H. Adler, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Avion. Dr. Adler has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CND Life Sci. Dr. Adler has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Precon. Dr. Adler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurocrine. The institution of Dr. Adler has received research support from NIH. The institution of Dr. Adler has received research support from Michael J. Fox Foundation. The institution of Dr. Adler has received research support from Arizona Biomedical Research Commission. Dr. Adler has received publishing royalties from a publication relating to health care.
Oded Abramsky, MD, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Frederick Andermann, MD, FRCPC, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Paola De Martino, MD, PhD No disclosure on file
Alexandros L. Georgiadis, MD No disclosure on file
Yuesong Gong No disclosure on file
Luc J. Regal, MD No disclosure on file
Carole Roue-Jagot No disclosure on file
Christine M. Sapienza, PhD No disclosure on file
Joseph H. Friedman, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
David A. Bennett, MD Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annovis. Dr. Bennett has received personal compensation in the range of $500-$4,999 for serving as a Consultant for New Amsterdam. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Dr. Bennett has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie.
Dorothee E. Chabas-Chanezon, MD, PhD No disclosure on file
Bradley C. Hiner, MD No disclosure on file
Suman Jayadev, MD Dr. Jayadev has nothing to disclose.
Patricia L. Kramer, PhD No disclosure on file
Jerry R. Mendell, MD, FÂ鶹´«Ã½Ó³»­ Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Vertex. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Mendell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sarepta Therapeutics . The institution of Dr. Mendell has received research support from Sarepta.
Serkan Ozakbas, MD Dr. Ozakbas has nothing to disclose.
Yun Qu, MD No disclosure on file
Walter A. Rocca, MD, MPH The institution of Dr. Rocca has received research support from National Institute on Aging - NIH. The institution of Dr. Rocca has received research support from National Heart, Lung, and Blood Institute - NIH.
Sandra D'Alfonso No disclosure on file
Stephen M. Graham, PhD No disclosure on file
Charlene E. Hafer-Macko, MD No disclosure on file
Monica Makhija, MD No disclosure on file
Serge Mrejen No disclosure on file
Andrea L. Rosso, MPH No disclosure on file
Jiong Shi, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche.
Patrice LaLive, MD Dr. LaLive has nothing to disclose.
Jean Marie Ahorro, MD No disclosure on file
Vivian E. Drory, MD Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Prof. Drory has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Prof. Drory has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison Pharma. The institution of Prof. Drory has received research support from Neurosense Therapeutics. The institution of Prof. Drory has received research support from AB Science. The institution of Prof. Drory has received research support from Biogen. The institution of Prof. Drory has received research support from Neuralight.
Clive P. Hawkins, MD No disclosure on file
Katherine L. Howard No disclosure on file
Gregory A. Jicha, MD, PhD Dr. Jicha has nothing to disclose.
Sarah A. Lewis No disclosure on file
William R. Markesbery, MD No disclosure on file
Michael Rezak, MD, PhD No disclosure on file
Eva Andermann, MD, PhD No disclosure on file
Thomas Beach Thomas Beach has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vivid Genomics. Thomas Beach has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche Diagnostics. The institution of Thomas Beach has received research support from National Institutes of Health. The institution of Thomas Beach has received research support from Michael J Fox Foundation . The institution of Thomas Beach has received research support from State of Arizona.
Steve M. Cordina, MD, FÂ鶹´«Ã½Ó³»­ Dr. Cordina has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Dr. Cordina has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech .
Antonio G. Gallo, MD No disclosure on file
Marc Gotkine, MD No disclosure on file
Peter H. King, MD The institution of Dr. King has received research support from Department of Veterans Affairs. The institution of Dr. King has received research support from NIH.
Khurram A. Siddiqui, MBBS, FRCP No disclosure on file
Vincenzo Silani, MD, FÂ鶹´«Ã½Ó³»­ Dr. Silani has nothing to disclose.
Martin Weber, MD Dr. Weber has nothing to disclose.
Bernard Brais, MD Dr. Brais has nothing to disclose.
Gwenn Garden, MD, PhD No disclosure on file
Tania Kuempfel, MD Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB Pharma. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Kuempfel has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen/Horizon.
Maureen Leehey, MD, FÂ鶹´«Ã½Ó³»­ Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Connected Research and Consulting. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Trinity Partners. Dr. Leehey has received personal compensation in the range of $0-$499 for serving as a Consultant for Sphenix Global Insight. Dr. Leehey has received personal compensation in the range of $0-$499 for serving as a Consultant for Olson Research Group. The institution of Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iris Medicine. The institution of Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Huron Consulting Services. Dr. Leehey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zynerba. The institution of Dr. Leehey has received research support from Michael J Fox Foundation. The institution of Dr. Leehey has received research support from Colorado Dept of Public Health and Environment. The institution of Dr. Leehey has received research support from Biogen. The institution of Dr. Leehey has received research support from US World Meds. The institution of Dr. Leehey has received research support from Vtesse. The institution of Dr. Leehey has received research support from NeuroDerm. The institution of Dr. Leehey has received research support from Denali. The institution of Dr. Leehey has received research support from Neuraly. The institution of Dr. Leehey has received research support from NINDS.
Bernadette Boden-Albala, DrPH Ms. Boden-Albala has nothing to disclose.
Sandra Donkervoort Ms. Donkervoort has nothing to disclose.
Rolf Martin No disclosure on file
Lorenzo Pinessi, MD No disclosure on file
Hanna Rosenmann No disclosure on file
Maarten Schrooten, MD No disclosure on file
Nauman Tariq, MD Dr. Tariq has received personal compensation for serving as an employee of NC neurological society .
Unsong Oh, MD Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Horizon Therapeutics. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech.
Takehiko Yanagihara, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Mayana Zatz No disclosure on file
Faye C. Francisco Ms. Francisco has nothing to disclose.
C.P. Zwanikken No disclosure on file
Volker Brinkmann, PhD No disclosure on file
Richelle A. Hemendinger, PhD No disclosure on file
Masato Kanazawa, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kanazawa has nothing to disclose.
Teshamae Monteith, MD, FÂ鶹´«Ã½Ó³»­ Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for American Headache Society . Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Pfizer. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Monteith has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merz. Dr. Monteith has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Axsome. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amneal. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva . Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Â鶹´«Ã½Ó³»­ . Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Cephalalgia. Dr. Monteith has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for New England Journal of Medicine JW. The institution of Dr. Monteith has received research support from AbbVie. The institution of Dr. Monteith has received research support from lilly. The institution of Dr. Monteith has received research support from Ipsen. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ with Medscape. Dr. Monteith has received personal compensation in the range of $500-$4,999 for serving as a Â鶹´«Ã½Ó³»­ with Massachusetts Medical Society . Dr. Monteith has a non-compensated relationship as a President Elect with Florida Society of Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a Editorial Board /Board Member with American Migraine Foundation that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a Board Member with International Headache Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a author with Pfizer that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a author with Abbvie that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Monteith has a non-compensated relationship as a author with Theranica that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Tetsuya Takahashi, PhD No disclosure on file
Jennifer A. Tracy, MD Dr. Tracy has nothing to disclose.
Alessandro Padovani, MD No disclosure on file
Rakefet Tsabari, MD No disclosure on file
Michel Sylvain, MD No disclosure on file
Fortunato Battaglia, MD Dr. Battaglia has nothing to disclose.
Matilde Inglese, MD, PhD Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for SANOFI GENZYME. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BIOGEN. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NOVARTIS. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for MERCK-SERONO. Dr. Inglese has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for ROCHE. Dr. Inglese has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MS Journal.
Alexander V. Panov, PhD No disclosure on file
James C. Stevens, MD No disclosure on file
Emrico Millefiorimi, PhD No disclosure on file
Adriana J. Carra, MD No disclosure on file
Zarife F. Sahenk, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Sahenk has nothing to disclose.
Richard A. Smith, MD Dr. Smith has received personal compensation for serving as an employee of Center for Neurologic Study. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received intellectual property interests from a discovery or technology relating to health care. Dr. Smith has received publishing royalties from a publication relating to health care. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving as a Inventor with Ionis Pharmaceutical.
Takayoshi Shimohata, MD, FÂ鶹´«Ã½Ó³»­ Dr. Shimohata has nothing to disclose.
Hitoshi Takahashi No disclosure on file
Daniel D. Truong, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Supernus. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amneal. The institution of Dr. Truong has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. The institution of Dr. Truong has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. The institution of Dr. Truong has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Truong has received research support from Abbvie. The institution of Dr. Truong has received research support from Aeon. The institution of Dr. Truong has received research support from Biogen. The institution of Dr. Truong has received research support from Bukwang. The institution of Dr. Truong has received research support from Cerevel. The institution of Dr. Truong has received research support from Eli Lilly. The institution of Dr. Truong has received research support from Enterin. The institution of Dr. Truong has received research support from Ipsen. The institution of Dr. Truong has received research support from Lundbeck. The institution of Dr. Truong has received research support from Neurocrine. The institution of Dr. Truong has received research support from Neuroderm. The institution of Dr. Truong has received research support from Parkinson Foundation. The institution of Dr. Truong has received research support from Prilenia. The institution of Dr. Truong has received research support from Revance. The institution of Dr. Truong has received research support from Sunovion. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has received publishing royalties from a publication relating to health care. Dr. Truong has a non-compensated relationship as a President with International Association for Parkinsonism and Related Disorders that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Thomas J. Wolfe, MD No disclosure on file
Sung Y. Yu Sung Y. Yu has received personal compensation for serving as an employee of Abbvie. Sung Y. Yu has received stock or an ownership interest from Abbvie.
Osama O. Zaidat, MD, FÂ鶹´«Ã½Ó³»­ Dr. Zaidat has nothing to disclose.
Dessa Sadovnick, PhD No disclosure on file
Pallavur Sivakumar No disclosure on file
Mingxin Tang, PhD No disclosure on file
Annachiara Cagnin No disclosure on file
Bernhard Hemmer, MD No disclosure on file
Senthil Sundaram No disclosure on file
Andrew Protter No disclosure on file
Eppie Yiu, MD The institution of Dr. Yiu has received research support from Biogen. The institution of Dr. Yiu has received research support from Roche . The institution of Dr. Yiu has received research support from PTC. The institution of Dr. Yiu has received research support from Pfizer .
Amy C. Rauchway, DO, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Nora Tarcic, PhD No disclosure on file
Isabelle Thiffault, PhD No disclosure on file
Jonathan Weinstein, MD Dr. Weinstein has received intellectual property interests from a discovery or technology relating to health care.
Didier Deffond No disclosure on file
Gary Steinberg, MD, PhD Dr. Steinberg has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for SanBio. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Zeiss. Dr. Steinberg has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Surgical Theater. Dr. Steinberg has received research support from National Institutes of Health. Dr. Steinberg has received research support from California Institute of Regenerative Medicine. Dr. Steinberg has received intellectual property interests from a discovery or technology relating to health care.
Caroline M. Tanner, MD, PhD, FÂ鶹´«Ã½Ó³»­ Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Evidera. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Tanner has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals/Cavion. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bial . Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Genentech. The institution of Dr. Tanner has received research support from Gateway LLC. The institution of Dr. Tanner has received research support from Roche\Genentech. The institution of Dr. Tanner has received research support from Michael J Fox Foundation . The institution of Dr. Tanner has received research support from National Institute of Health . The institution of Dr. Tanner has received research support from Department of Defense. Dr. Tanner has received personal compensation in the range of $500-$4,999 for serving as a Faculty, CME presentation with Medscape /WebND.
Timothy L. Vollmer, MD, FÂ鶹´«Ã½Ó³»­ The institution of Dr. Vollmer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen IDEC. The institution of Dr. Vollmer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Siranax. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Celgene. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Meyers Squib. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viela Bios. The institution of Dr. Vollmer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. The institution of Dr. Vollmer has received research support from Rocky Mountain MS Center. The institution of Dr. Vollmer has received research support from Biogen. The institution of Dr. Vollmer has received research support from Actelion. The institution of Dr. Vollmer has received research support from Genentech/Roche. The institution of Dr. Vollmer has received research support from Anokion. The institution of Dr. Vollmer has received research support from TG Therapeutics.
Soo Y. You, MD No disclosure on file
Catarina Quinzii Hirano, MD No disclosure on file
Bianca Weinstock-Guttman, MD Dr. Weinstock-Guttman has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genzyme &Sanofi. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen . Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Horizon. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weinstock-Guttman has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Dr. Weinstock-Guttman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Weinstock-Guttman has received personal compensation in the range of $0-$499 for serving as a Reviewer with NIH.
E. Ann Yeh, MD, MA, FRCPC Dr. Yeh has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pipeline therapeutics. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for SCN. Dr. Yeh has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. The institution of Dr. Yeh has received research support from CIHR. The institution of Dr. Yeh has received research support from National MS Society. The institution of Dr. Yeh has received research support from SickKids Foundation. The institution of Dr. Yeh has received research support from MSSC. The institution of Dr. Yeh has received research support from Garry Hurvitz Foundation. The institution of Dr. Yeh has received research support from Leong Centre. The institution of Dr. Yeh has received research support from OMSLife. The institution of Dr. Yeh has received research support from Canada's Drug Agency. Dr. Yeh has received personal compensation in the range of $0-$499 for serving as a Author with Medscape. Dr. Yeh has a non-compensated relationship as a Editorial Board with Neurology that is relevant to Â鶹´«Ã½Ó³»­ interests or activities. Dr. Yeh has a non-compensated relationship as a Editorial Board with MSJ that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
Helene Zephir Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BIogen Idec. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for novartis. Helene Zephir has received personal compensation in the range of $0-$499 for serving as a Consultant for BMS. Helene Zephir has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion.
Marcondes C. Franca, Jr., MD Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PTC. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Franca has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Franca has received research support from FARA.
Laura F. Santoso No disclosure on file
Gaofeng Wang No disclosure on file
Eleonora Cocco No disclosure on file
John T. Wells, MD Dr. Wells has nothing to disclose.
Evan Y. Snyder, MD, PhD No disclosure on file
Ugonma N. Chukwueke, MD Dr. Chukwueke has nothing to disclose.
Eric E. Adelman, MD The institution of Dr. Adelman has received research support from PCORI.
Hai Chen, MD, PhD Dr. Chen has nothing to disclose.
Erika L. Wexler, MD No disclosure on file
Michael Weller, MD Dr. Weller has received personal compensation in the range of $0-$499 for serving as a Consultant for Neurosense. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Philogen. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Servier. Dr. Weller has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curevac. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Orbus. Dr. Weller has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novocure. The institution of Dr. Weller has received research support from Versameb.
Melanie Glenn, MD No disclosure on file
David Collas, MD No disclosure on file
Govind Nair No disclosure on file
Tobias B. Kulik, MD, FÂ鶹´«Ã½Ó³»­ Dr. Kulik has nothing to disclose.
Agust Hilmarsson, MD No disclosure on file
Stacey L. Hughes No disclosure on file
Brian Ahuja, MD No disclosure on file
Agyepong Oware, MD No disclosure on file
Pouya Tahsili-Fahadan, MD Dr. Tahsili-Fahadan has received publishing royalties from a publication relating to health care.
Nikolaos Evangelou, PhD Dr. Evangelou has received personal compensation in the range of $0-$499 for serving as a Consultant for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Evangelou has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis . Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for UK crown prosecution service. Dr. Evangelou has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Novartis .
Zulfi Haneef, MD, MBBS, MRCP, FÂ鶹´«Ã½Ó³»­ Dr. Haneef has received publishing royalties from a publication relating to health care.
Sean Grimm, MD Dr. Grimm has nothing to disclose.
Yumna Saeed, MD No disclosure on file
Nina M. Browner, MD The institution of Dr. Browner has received research support from Parkinson Foundation Center of Excellence Grant. The institution of Dr. Browner has received research support from Parkinson Foundation Community Outreach Grant .
Jan-Thies Van Asseldonk, MD, PhD No disclosure on file
Bridget R. Mueller, MD, PhD Dr. Mueller has nothing to disclose.
Michael L. James, MD Dr. James has nothing to disclose.
Katy Eichinger, PhD, PT, DPT, NCS Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Fulcrum. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Avidity. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for DyneTherapeutic. Dr. Eichinger has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Eichinger has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for TRiNDS. The institution of Dr. Eichinger has received research support from Charcot Marie Tooth Association. The institution of Dr. Eichinger has received research support from Muscular Dystrophy Association. Dr. Eichinger has received intellectual property interests from a discovery or technology relating to health care.
Angeliki Tsapanou, PhD Dr. Tsapanou has nothing to disclose.
Andreas A. Roussakis No disclosure on file
Sean Rogers, MD, PhD No disclosure on file
Matteo Pardini, MD, PhD No disclosure on file
Claire A. Sheldon, MD, PhD No disclosure on file
Meelee Tom No disclosure on file
Rebecca G. Straus Farber, MD Dr. Straus Farber has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics.
Pradeep C. Bollu, MD Dr. Bollu has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie.
Michelle C. Johansen, MD Dr. Johansen has received research support from NINDS/NIA. Dr. Johansen has received research support from American Heart Association.
Marco Elegante No disclosure on file
Braeden D. Newton No disclosure on file
Malgorzata Siger No disclosure on file
Manish Modi No disclosure on file
Massimo Del Sette No disclosure on file
Albert Cook, MD No disclosure on file
Elisabeth Donahey, PharmD No disclosure on file
Halinder Mangat, MD No disclosure on file
Zheng Liu Zheng Liu has nothing to disclose.
Addie Patterson, DO Dr. Patterson has received personal compensation in the range of $500-$4,999 for serving as a Content creator with Medical insights group.
David A. Abernethy, FRACP, MB, ChB No disclosure on file
Vijay Sharma No disclosure on file
Pierangelo Barbero, MD No disclosure on file
Paul Gilbert, PhD Dr. Gilbert has nothing to disclose.
Annemie Ribbens Annemie Ribbens has received personal compensation for serving as an employee of icometrix. Annemie Ribbens has stock in icometrix. Annemie Ribbens has received intellectual property interests from a discovery or technology relating to health care.
Joost Raaphorst, MD Dr. Raaphorst has nothing to disclose.
Sara Khan, MD Dr. Khan has nothing to disclose.
John P. Bunka, DO Dr. Bunka has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Supernus pharmaceutical.
Francesca Brett No disclosure on file
Saqib A. Chaudhry, MD Dr. Chaudhry has nothing to disclose.
Farhaan S. Vahidy, MBBS, PhD Dr. Vahidy has nothing to disclose.
Kevin E. Chapman, MD No disclosure on file
Jessica F. Robb, MD No disclosure on file
Lisena Hasanaj Ms. Hasanaj has nothing to disclose.
John D. Fisk, PhD The institution of Dr. Fisk has received research support from Canadian Institutes of Health Research. The institution of Dr. Fisk has received research support from Multiple Sclerosis Society of Canada. Dr. Fisk has received publishing royalties from a publication relating to health care.
Cindy Yoon No disclosure on file
Cristina Sampaio, Prof No disclosure on file
Sarah Clark No disclosure on file
Jill A. Goslinga, MD An immediate family member of Dr. Goslinga has received intellectual property interests from a discovery or technology relating to health care. An immediate family member of Dr. Goslinga has received intellectual property interests from a discovery or technology relating to health care.
Dustin M. Anderson, MD No disclosure on file
Douglas M. Turnbull No disclosure on file
Jalesh Panicker Jalesh Panicker has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Coloplast . Jalesh Panicker has received publishing royalties from a publication relating to health care.
Venugopalan Y. Vishnu, MD The institution of Dr. Vishnu has received research support from Department of Health Research.
Sam H. Horng, MD, PhD The institution of Dr. Horng has received research support from National Institutes of Health . The institution of Dr. Horng has received research support from Jayne and Harvey Beker Foundation .
Malik Fakhar, MD Dr. Fakhar has nothing to disclose.
Candice Chapouly, PhD, PharmD No disclosure on file
Michael Shaw No disclosure on file
Sandrine Herbelet, DVM No disclosure on file
Anindita Deb, MD, FÂ鶹´«Ã½Ó³»­ Dr. Deb has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Altec.
Santoshi Billakota, MD No disclosure on file
Claire E. Carrazco, DO No disclosure on file
Sirwan K. Darweesh, MD, PhD No disclosure on file
Eung-Seok Lee No disclosure on file
Rosa Cortese No disclosure on file
Nargiza Chekeeva Nargiza Chekeeva has nothing to disclose.
Maurizio Melis No disclosure on file
Prachi T. Parikh, MD Dr. Parikh has nothing to disclose.
Rahe N. Hiraldo-Delgado, MD No disclosure on file
Charlotte E. Zisman, MD No disclosure on file
Ela M. Akay No disclosure on file
Matiur Rahman, MD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Carsten Finke, MD Carsten Finke, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myer Squibb. The institution of Carsten Finke, MD has received research support from Euroimmun.
Efstathia Chronopoulou No disclosure on file
Francisco Javier Ricart Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis. Francisco Javier Ricart has received personal compensation for serving as an employee of Novartis.
Tyler Koehn, MD Dr. Koehn has nothing to disclose.
Pietro Osvaldo Luigi Annovazzi No disclosure on file
Sofiati Dian No disclosure on file
Frank Wolters No disclosure on file
Christopher Chow No disclosure on file
Alice Laroni Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alice Laroni has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alice Laroni has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alice Laroni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biogen. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Teva. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Alice Laroni has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. The institution of Alice Laroni has received research support from Fondazione Italiana Sclerosi MUltipla . The institution of Alice Laroni has received research support from Ministero Salute. The institution of Alice Laroni has received research support from Ministero UNiversità.
Pournamy Sarathchandran, MD, MBBS, PhD, FÂ鶹´«Ã½Ó³»­ No disclosure on file
Lauren Zajac Ms. Zajac has received personal compensation for serving as an employee of Alexion, AstraZeneca Rare Disease.